Research Articles (Immunology)

Permanent URI for this collectionhttp://hdl.handle.net/2263/1864

Browse

Recent Submissions

Now showing 1 - 20 of 576
  • Item
    Viral load suppression trends among young people with perinatally-acquired HIV on long-term antiretroviral therapy in Ndwedwe Local Municipality, South Africa
    Mncwango, Silindile Lilly; Mbatha, Nothando; Rossouw, Theresa; Ngcobo, Sanele (Taylor and Francis, 2026-09-23)
    Young people with perinatally acquired HIV (YPpHIV) in rural South Africa face persistent challenges in achieving and sustaining viral load (VL) suppression despite long-term antiretroviral therapy (ART). We conducted a retrospective cohort study using routinely collected TIER.Net data from eight primary healthcare facilities in Ndwedwe Local Municipality, KwaZulu-Natal, including YPpHIV aged 10-35 years who initiated ART before 2015 and had at least 10 years of treatment. Longitudinal VL trends were summarised across ART-duration categories (0-3, 4-6, 7-10, 11-15, and ≥16 years), and repeated VL outcomes were assessed using Gaussian and binary generalised estimating equations accounting for within-participant correlation. Suppression was evaluated at <50, <400 and <1000 copies/mL, with adjusted odds ratios reported for each threshold. The cohort comprised 542 participants (mean age 16.4 years; 53.0% female). Viral suppression improved with increasing ART duration, while adjusted mean log10 VL declined progressively; at ≥16 years, the odds of VL <50 suppression were more than sixfold higher than at 0-3 years. Clinic of care was associated with virological outcomes, whereas sex and age at ART initiation were not consistently associated. Strengthening long-term adherence support, maintaining effective ART, and addressing clinic-level variation may support durable viral suppression in YPpHIV.
  • Item
    Efficacy and safety of EG12014 (Biosimilar Trastuzumab) compared to reference trastuzumab in HER2-positive early breast cancer : a phase III randomized study
    Huang, Chiun-Sheng; Dzagnidze, Giorgi; Grohmann-Izay, Barbara; Liu, Lee-Cheng; Llinas-Quintero, Nestor; Lin, Ae-Ning; Mishra, Anand K.; Pominchuk, Denys; Prokharau, Aliaksandr; Rapoport, Bernardo Leon; Semiglazov, Vladimir; Tseng, Ling-Ming; Ruiz, Eduardo Y.; Loibl, Sibylle (Springer, 2026-09-24)
    INTRODUCTION : Trastuzumab biosimilar EG12014 (Herwenda®; EirGenix/Sandoz) was approved by the European Medicines Agency (EMA) in 2023. We aim to demonstrate equivalent efficacy, and to compare safety, immunogenicity, and pharmacokinetic (PK) profiles, of EG12014 and reference trastuzumab (ref-TRA) in early breast cancer (EBC). METHODS : This Phase III, randomized, multicenter, double-blind study included adult patients with EBC. In the neoadjuvant phase, patients received epirubicin and cyclophosphamide for four cycles, then were randomized (1:1) to four cycles of EG12014 or ref-TRA (loading/maintenance dose: 8/6 mg/kg) with paclitaxel. Following surgery, patients continued adjuvant EG12014, or were rerandomized (1:1) from ref-TRA to ref-TRA or EG12014. Patients completed 12 months of treatment. The primary endpoint was centrally-assessed pathological complete response (pCR; defined as ypT0/is ypN0) at the time of surgery. Additional efficacy, safety, immunogenicity, and PK endpoints were evaluated. RESULTS : In the neoadjuvant phase, 405 and 402 patients were randomized to EG12014 and ref-TRA, respectively. In the adjuvant phase, 386 patients continued EG12014, 188 continued ref-TRA, and 188 switched from ref-TRA to EG12014. The primary objective, to demonstrate equivalent efficacy between EG12014 and ref-TRA, was achieved: the risk difference between treatment arms in pCR rate was − 0.004 (95% CI − 0.072 to 0.065), with the 95% CI entirely within the predefined equivalence margin of − 0.13 to 0.13 (EMA requirement). Equivalence was also demonstrated regarding the risk ratio, with a relative risk of 0.992 (90% CI 0.880–1.118) and the 90% CI completely within the predefined equivalence margin of 0.741–1.349 (US Food and Drug Administration requirement). Secondary efficacy endpoints, including overall response prior to surgery and overall survival, were also comparable between treatments. Safety, immunogenicity and PK profiles were comparable between treatments and were not impacted by switching. CONCLUSION : Trastuzumab biosimilar EG12014 and ref-TRA have equivalent efficacy, and comparable safety, immunogenicity, and PK profiles, in patients with EBC.
  • Item
    Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023
    Stark, Benjamin A.; DeCleene, Nicole K.; Desai, Emily C.; Hsu, Johnathan M.; Johnson , Catherine O.; Lara-Castor , Laura; LeGrand, Kate E.; Prof Bhoomadevi`, A.; Aalipour, Mohammad Amin; Aalruz, Hasan; Abafita, Bedru J.; Abaraogu, Ukachukwu O.; Abavisani, Mohammad; Abbas , Nasir; Abbasi, Madineh; Abbasian, Mohammadreza; Abbastabar, Hedayat; Abd Al Magied, Abdallah H.A.; Abd ElHafeez, Samar; Abdelalim, Prof Ahmed; Abdelfattah, Omar M.; Abdel-Hameed, Prof Reda; Abdelnabi, Mahmoud; Abdel-Rahman, Prof Wael M.; Abdi, Parsa; Abdisa, Wakgari Mosisa; Abdissa , Daba; Abdous, Arman; Abdullah, Mujahid; Abdullahi, Auwal; Abdykerimova, Kulmira; Abebe, Mesfin; Abedi, Aidin; Abedi, Armita; Abejew, Asrat Agalu; Abhilash , E.S.; Abiodun, Olugbenga Olusola; Abiodun, Prof Olumide; Abo Kasem, Rahim; Aboagye, Richard Gyan; Abohashem, Shady; Abolhassani , Hassan; Abonie, Ulric Sena; Aborode, Abdullahi Tunde; Abourashed, Nagah Mohamed; Abramov, Dmitry; Abreu, Prof Lucas Guimarães; Abtahi, Prof Dariush; Abu Farha, Prof Rana Kamal; Abubakar, Aminu Kende Kende; Abubakar, Ibrahim Jatau; Abu-Elala , Prof Nermeen; Abu-Gharbieh, Prof Eman; Abukhadijah, Hana J.; Aburuz, Prof Salahdein; Abushanab, Dina; Acharya, Anirudh Balakrishna; Acharya, Apurba; Acharya, Swetha; Achore, Meshack; Adal, Ousman; Adams, Lisa C.; Adamu, Lawan Hassan; Adão, Prof Rui; Addo, Isaac Yeboah; Adebayo, Oladimeji Muritala; Adebisi, Tajudeen Adesanmi; Adedia, David; Adedokun, Kamoru Ademola; Adegbile, Oluwatobi E.; Adegboye, Prof Oyelola A.; Adegoke, Nurudeen A.; Adekanmbi, Victor; Adeleke, Olumide Thomas; Adetunji , Prof Charles Oluwaseun; Adeyomoye , Olorunsola Israel; Adha, Rishan; Adhikari, Prof Kishor; Adhikary , Ripon Kumar; Adikusuma, Wirawan; Adl Parvar, Tanin; Adnan, Mohd; Adnani, Qorinah Estiningtyas Sakilah; Adoma, Prince Owusu; Adzigbli, Leticia Akua; Adzrago, David; Afifi , Ahmed M.; Afolabi, Habeeb Abiodun; Afrashteh, Fatemeh; Afrooghe, Arya; Afzal, Muhammad Sohail; Afzal, Prof Saira; Agampodi , Prof Suneth Buddhika; Agarwal, Dhiraj Motilal; Agarwal, Prof Gina; Agarwal, Prerna; Ageru, Temesgen Anjulo; Aggarwal, Navidha; Aghajanian, Sepehr; Agostinis Sobrinho, César; Agyemang-Duah, Williams; Ahadi, Mahsa; Ahammed , Benojir; Ahinkorah, Bright Opoku; Ahmad , Aqeel; Ahmad, Prof Fuzail; Ahmad, Khurshid; Ahmad , Prof Muayyad M.; Ahmad, Sajjad; Ahmad , Shoaib; Ahmad, Tauseef; Ahmadzadeh, Koohyar; Ahmed, Ali; Ahmed, Anisuddin; Ahmed, Ayman; Ahmed, Gasha Salih; Ahmed, Haroon; Ahmed , Prof Junaid; Ahmed, Prof Luai A.; Ahmed, Mehrunnisha Sharif; Ahmed, Meqdad Saleh; Ahmed, Muktar Beshir; Ahmed, Mushood; Ahmed, Naveed; Ahmed , Nesredin; Ahmed, Shabbir; Ahmed, Syed Anees; Ajakwe, Simeon Okechukwu; Ajami, Marjan; Aji , Budi; Akalu, Yonas; Akeju, Oluwasefunmi; Akhigbe, Roland Eghoghosoa; Akhmedullin , Ruslan; Akindele, Prof Mukadas Oyeniran; Akinosoglou, Karolina; Akiska, Yagiz Matthew; Akkaif, Mohammed Ahmed; Akram, Hammad; Akrami, Ashley E.; Al Awaidy, Salah; Al Hamad, Hanadi; Al Hasan, Syed Mahfuz; Al Omari, Prof Omar; Al Qadire , Prof Mohammad; Al Thaher, Yazan; Al Zoubi, Mohammad Ahmmad Mahmoud; Al-Ajlouni, Yazan; Alalwan, Tariq A.; Al-Aly, Ziyad; Alam, Khurshid; Alam, Prof Mohammad Khursheed; Alam , Mostafa; Alam, Zufishan; Al-amer, Rasmieh Mustafa; Alansari, Amani; Alanzi , Turki M.; Alarifi, Prof Abdullah; Al-Ashwal, Fahmi Y.; Alavi, Rashid; Albashtawy , Prof Mohammed; Al-Daken, Laila Ismael; Aldawsari, Khalifah A.; Aldhahir, Abdulelah Mastour; Aldossary, Mohammed S.; Aleidi , Shereen M.; Alemayehu, Bezawit Abeje; Alemayehu , Tekletsadik Tekleslassie; Alemi, Hediyeh; Algammal , Prof Abdelazeem M.; Al-Gheethi, Adel Ali Saeed; Alhajri, Noora; Alhalaiqa, Prof Fadwa Naji; Al-Hanawi , Mohammed Khaled; Alharrasi, Maryam; Alhumaidi, Ashraf; Ali , Akhtar; Ali, Endale Alemayehu; Ali, Prof Kamran; Ali , Mohammad Daud; Ali, Mohammed Usman; Ali, Rafat; Ali, Sameer A.; Ali, Syed Shujait; Ali, Syed Yusuf; Al-Ibraheem, Prof Akram; Al-Iede, Montaha; Alif, Sheikh Mohammad; Alinejad Rokny, Prof Hamid; Al-Jabi, Prof Samah W.; Aljawadi , Mohammad Hasan; Aljofan, Mohamad; Aljunid, Prof Syed Mohamed; Alkhatib, Prof Ahmad; Alkousheh, Hazim; Alla, Prof François; Al-Mamun, Md.; Al-Marwani , Sabah; Almasri, Prof Nihad A.; Almazan, Joseph Uy; Almidani, Omar; Almobayed, Amr; Alnaeem, Mohmmad Minwer; Al-Naqeb, Ghanya Naji; Alniss, Hasan Yaser; Alomari, Prof Mahmoud A.; Alosta, Mohammad R.; Alqahtani 263, 264; Alqudimat, Mohammad R.; Alrawashdeh, Ahmad; Alrimawi , Intima; Alrousan , Sahel Majed; Alsabri, Mohammed A.; Alsakarneh, Saqr; Alshehri , Mansour Abdullah; Altaany, Zaid; Altaf , Awais; Al-Tammemi , Alaa B.; Al-Tawfiq, Prof Jaffar A.; Alvis-Guzman, Prof Nelson; Alvis-Zakzuk, Nelson J.; Alwafi, Hassan; Al-Wardat, Mohammad; Al-Worafi, Prof Yaser Mohammed; Aly, Prof Hany; AlZahmi, Amal; Alzahrani , Hosam; Alzoubi, Abdallah; Alzoubi, Prof Karem H.; Al-Zubayer, Md Akib; Amafah, Ekiyor Joseph; Amafah, Joy; Amani-Beni, Reza; Amanollahi , Mobina; Amaravadi, Sampath Kumar; Amegah, Prof Adeladza Kofi; Amegbor, Prince M.; Amenah, Michel Adurayi; Amidi , Bardia; Amin, Prof Tarek Tawfik; Amindarolzarbi , Alireza; Amini-Rarani, Mostafa; Amini-Salehi, Ehsan; Aminorroaya, Arya; Aminzare, Majid; Amiri, Sohrab; Ammirati, Enrico; Amobonye, Ayodeji; Ampon-Wireko, Sabina; Amu , Hubert; Amugsi, Dickson A.; Amusa, Ganiyu Adeniyi; Anagnostakis, Filippos; Ananda, Roshan A.; Anaraki, Nazanin; Ancuceanu, Prof Robert; Anderlini , Deanna; Anderson, David B.; Anderson, Jason A.; Andrei, Prof Catalina Liliana; Ang, Song Peng; Angappan, Santhalakshmi; Anh, Nguyen Hoang; Anil , Abhishek; Ansari 337 , 338; Ansariadi, Ansariadi; Anteneh , Rahel Mulatie; Anuoluwa, Boluwatife Stephen; Anuoluwa , Iyadunni Adesola; Anvari, Saeid; Anwar, Saleha; Anwer, Razique; Anyasodor, Anayochukwu Edward; Appiah, Francis; Arab, Juan Pablo; Arabloo, Jalal; Arafa, Prof Elshaimaa A.; Arafat, Mosab; Aravkin, Aleksandr Y.; Areda , Demelash; Aremu, Olatunde; Arias de la Torre, Jorge; Armocida , Benedetta; Arockiaraj, Prof Jesu; Arooj, Prof Mahwish; Arshadi, Mahdi; Artamonov, Anton A.; Arumugam, Ashokan; Asaduzzaman, Muhammad; Asdaq, Prof Syed Mohammed Basheeruddin; Asefa , Shewatatek Melaku Melaku; Asgary, Amirhossein; Asghari-Jafarabadi, Prof Mohammad; Ashagre, Alebachew Fasil; Ashames, Akram; Ashfaq , Muhammad; Ashraf, Hamza; Ashraf, Muhammad Abdul Basit; Ashraf, Tahira; Ashrafi, Mitra; Aslam, Muhammad Shahzad; Asrat , Anemaw A.; Asri, Yuni; Assefa, Dereje Zewdu; Assembekov , Batyrbek; Astell-Burt, Prof Thomas; Athari , Seyyed Shamsadin; Atout, Maha Moh'd Wahbi; Atreya, Alok; Atta, Julie Alaere; Aurangzeb , Khursheed; Ausloos, Prof Marcel; Avula, Sreekant; Awedew, Atalel Fentahun; Awoke, Mamaru Ayenew; Awotidebe, Adedapo Wasiu; Awoyomi, Oluwabusayo Olufunke; Axame, Wisdom Kudzo; Ayele, Belete Achamyelew; Ayyad , Mohammed; Azadnajafabad, Sina; Azadnia, Arian; Azami, Hiva; Azarboo, Alireza; Azhar, Masood; Aziz, Mohd Yusmaidie; Aziz, Sadat Abdulla; Azizan, Amin; Azizi, Hosein; Azzam, Ahmed Y.; Azzolino, Domenico; Babatope, Abisola Esther; Babu, Abraham Samuel; Babu, Prof Giridhara Rathnaiah; Badar, Muhammad; Badran, Prof Alaa Aboelnour; Bagga, Prof Arvind; Baghcheghi, Nayereh; Bagheri, Prof Nasser; Bagheri, Sara; Baghizadeh , Elahe; Baghizadeh, Fereshteh; Baghizadeh, Sana; Bahrami Taghanaki , Pegah; Bahreini, Razieh; Bai, Ruhai; Bains, Prof Lovenish; Bakkannavar, Shankar M.; Bako, Abdulaziz T.; Balakrishnan, Senthilkumar; Balasubramanian, Madhan; Balcha, Wondu Feyisa; Baldereschi, Marzia; Balkis , Maher; Baloch, Farhala; Balogun , Saliu A.; Balooch Hasankhani , Mohammadreza; Baltatu, Prof Ovidiu Constantin; Bam, Kiran; Banda, Kondwani Joseph; Bandaru, Praneeth Kumar Reddy; Banik, Palash Chandra; Banik, Rajon; Bansal , Hansi; Bansal , Kannu; Barati, Shirin; Barbic , Franca; Bardhan, Mainak; Barengo, Noel C.; Barker-Collo, Prof Suzanne Lyn; Barqawi , Hiba Jawdat; Barteit, Sandra; Barua, Lingkan; Bashar, MD Abu; Bashir, Shahid; Bashiri, Azadeh; Aliabadi, Somaye Bashiri; Basri, Rehana; Bastan , Mohammad-Mahdi; Basu, Saurav; Batra, Kavita; Bauckneht, Prof Matteo; Bayat, Mahdis; Bayat, Reza; Bayih, Mulat Tirfie; Bayisa, Feyisa Shasho; Beeraka, Prof Narasimha M.; Behnoush, Amir Hossein; Bekele, Alehegn; Belayneh , Asnake Gashaw; Belete, Abebe Gedefaw; Belete, Abel Cherkos; Bilgin, Gokce Belge; Bello, Prof Bashir; Bello, Olorunjuwon Omolaja; Bello, Umar Muhammad; Belo , Prof Luis; Belsti , Yitayeh; Benfor, Bright; Bennett, Derrick A.; Bensenor, Isabela M.; Bente Kamal Tune, Samiun Nazrin; Benzige, Catherine P.; Bera, Om Prakash; Berezvai , Zombor; Bergami , Maria; Berhe, Kenfe Tesfay; Berhie, Alemshet Yirga; Berihun, Abiye Assefa; Bermudez, Amiel Nazer C; Bernstein , Robert S.; Bhadoria, Ajeet Singh; Bhagavathula, Akshaya Srikanth; Bhandari, Buna; Bhardwaj, Nikha; Bhardwaj , Prof Pankaj; Bhaskar, Sonu; Bhattacharjee , Priyadarshini; Bhattacharjee, Shuvarthi; Bhatti , Prof Gurjit Kaur; Bhatti, Prof Jasvinder Singh; Bhatti, Prof Rajbir; Bhuyan, Soumitra S.; Biadgilign, Sibhatu Kassa; Bilgin, Can; Bilgin 528 529, 530; Birck, Marina G.; Birhan, Mekuriaw Mesfin; Birru, Eshetie Melese; Biswas, Bijit; Biswas, Mohammad Shahangir; Biswas, Monirujjaman; Biswas, Raaj Kishore; Bizzozero-Peroni, Bruno; Bjørge, Prof Tone; Bodhare, Prof Trupti; Bodunrin, Aadam Olalekan; Bogale , Sitotaw Kerie; Bohn , Lucimere; Bolarinwa, Obasanjo Afolabi; Boloor, Archith; Hashemi, Milad Bonakdar; Bonakdarhashemi , Moein; Basara, Berrak Bora; Borhany, Hamed; Borran, Mina; Bosoka , Samuel Adolf; Botero Carvajal, Prof Alejandro; Boyko, Edward J.; Bozic, Prof Marija M.; Braithwaite, Dejana; Brant, Prof Luisa C.; Brauer, Prof Michael; Breitner, Susanne; Brenner , Prof Hermann; Bressem, Keno K.; Britton, Gabrielle; Bugiardini, Prof Raffaele; Bui, Linh Phuong; Bulamu, Norma B.; Bulto, Lemma N.; Burhan, Asmat; Burley , Claire V.; Burns, Richard A.; Busch, Felix; Bustanji, Prof Yasser; Butt, Prof Nadeem Shafique; Butt, Zahid A.; C.J, Sanjay; Cabral , Lucas Scotta; Cairns, Rose; Barsbay, Mehtap Çakmak; Calina, Prof Daniela; Cámera, Prof Luis Alberto; Campos, Prof Luciana Aparecida; Campos-Nonato, Ismael; Canales, Robert A.; Cao, Si; Capodici, Angelo; Caravaca-Morera, Jaime Alonso; Cárdenas, Prof Rosario; Carletti, Claudia; Carreras, Giulia; Carugno, Andrea; Carvalho , Prof Felix; Carvalho, Márcia; Carvalho-e-Silva, Ana Paula; Castaldelli-Maia, Prof Joao Mauricio; Catapano, Prof Alberico L.; Cattaruzza, Maria Sofia; Cegolon, Prof Luca; Cembranel, Prof Francieli; Cenderadewi , Muthia; Cenko, Edina; Cerin, Prof Ester; Cerovac , Prof Anis; Cerrai, Sonia; Chadwick, Joshua; Shivamadhu , Madhu Chakkere; Chakraborty, Aditya; Chakraborty, Prof Chiranjib; Chakraborty, Sandip; Chan, Jeffrey Shi Kai; Chandika, Rama Mohan; Chandradasa, Prof Miyuru; Chandramouli Bellur , Vinay; Chandrasekar, Eeshwar K.; Chang, Qinghua; Charan, Jaykaran; Chattu, Vijay Kumar; Chaudhary, Anis Ahmad; Chaudhuri , Sirshendu; Chavoshi, Mohammadreza; Chen, An-Tian; Chen, Guangjin; Chen, Haiyan; Chen, Hana; Chen, Haowei; Chen, Meng Xuan; Chen, Simiao; Chen , Xiang; Cheung , Ka Ching; Chew, Derek S.; Chew , Nicholas W.S.; Chhabra, Ravindresh; Chi , Gerald; Chichagi, Fatemeh; Chimoriya, Ritesh; Ching, Patrick R.; Chiriacò, Martina; Chirinos-Caceres , Jesus Lorenzo; Chitheer, Abdulaal; Cho, So Mi Jemma; Cho, William C.S.; Chong, Bryan; Chong , Yuen Yu; Chopra, Hitesh; Chopra, Shivani; Chou, Hou In; Choudhari, Prof Sonali Gajanan; Chowdhury, Enayet Karim; Chowdhury, Prof Rajiv; Chowdhury, Sreshtha; Christensen, Prof Hanne; Christopher, Prof Devasahayam J.; Chu, Dinh-Toi; Chukwu, Isaac Sunday; Chung, Sheng-Chia; Chung, Sunghyun; Cioffi, Iolanda; Cohen, Aaron J.; Columbus , Alyssa; Conde, Prof Joao; Congly, Stephen E.; Conrad , Nathalie; Conti, Sara; Cortesi , Paolo Angelo; Cosma, Claudia; Costa, Vera Marisa; Criqui, Prof Michael H.; Cruz-Martins, Prof Natalia; Da Silva, Alanna Gomes; Dababo, Nour; Dabbagh , Prof Ali; Dabo, Bashir; Dadras, Omid; Dai , Xiaochen; Dai , Zhaoli; Dalakoti, Mayank; Damasceno , Prof Albertino Antonio Moura; D'Amico, Prof Emanuele; Danaei, Bardia; Dandona, Prof Lalit; Dandona, Prof Rakhi; Dang, Anh Kim; D'Anna, Lucio; Danpanichkul , Pojsakorn; Danso, Samuel E.; Darcho, Samuel Demissie; Darouei, Bahar; Darvishi Cheshmeh Soltani, Reza; Das, Saswati; Dashtkoohi, Mohadese; Davletov , Dimash; Davletov, Prof Kairat; Dayasiri, Prof Kavinda; De la Hoz, Prof Fernando Pio; Deb, Novonil; Dehadrai, Aniket; Del Bo', Cristian; Del Riccio, Marco; Delsoz, Mohammad; Demeke , Dessalegn; Deng, Ke; Denova-Gutiérrez, Edgar; Derbew Molla, Meseret; Dergaa, Ismail; Derseh, Hunegnaw Almaw; Dervišević, Emina; Desai , Hardik Dineshbhai; Desai, Rupak; Desta, Abraham Aregay; Deuba, Keshab; Devarakonda, Pradeep Kumar; Devegowda, Devananda; Dewan, Syed Masudur Rahman; Dhali, Arkadeep; Dhama , Kuldeep; Dhamija, Prof Rajinder K.K.; Dhimal, Meghnath; Dhungel , Bibha; Di Bella, Prof Stefano; Di Pumpo, Marcello; Dias da Silva, Prof Diana; Diaz, Luis Antonio; Dima, Adriana; Ding, Xueting; Do, Huyen; Do , Thao Huynh Phuong; Do Amaral Júnior, Orlando Luiz Luiz do Amaral; Doegah, Phidelia Theresa; Dohare, Sushil; Dokova, Prof Klara Georgieva; Dondi, Francesco; D'Oria, Prof Mario; Dorostkar, Fariba; Dos Santos, Wendel Mombaque; Doshi , Ojas Prakashbhai; Dowou, Robert Kokou; Dresse, Menayit Tamrat; Dsouza, Viola Savy; Du, Mi; Dube, John; Dumbili, Emeka W.; Duncan , Prof Bruce B.; Dunne, Jennifer; Duraes, Prof Andre Rodrigues; Durojaiye, Oyewole Christopher; Dutta, Siddhartha; Dutta, Sulagna; E’mar, Abdel Rahman; Ebohon, Osamudiamen; Ebraheim, Lamiaa Labieb Mahmoud; Ebrahimi, Alireza; Ebrahimi , Mohammad Hossein; Ebrahimi , Rasoul; Ebrahimi, Sara; Edinur, Hisham Atan; Efendi, Ferry; Eftekhari, Behrad; Eghbali, Foolad; Eghdami, Shayan; Sedeh, Ashkan Eighaei; Eini, Ebrahim; Ekholuenetale , Michael; Ekundayo, Temitope Cyrus; El Arab, Rabie Adel; El Morsi, Prof Doaa Abdel Wahab; El Sayed Zaki, Prof Maysaa; Eladl , Mohamed Ahmed; Elagali 8, Ahmed Elabbas Mustafa; Elalfy, Aya; El-Ashker , Prof Said; El-Dahiyat, Prof Faris; Elgendy, Islam Y.; Elhadi, Muhammed; El-Huneidi, Prof Waseem; Elkannishy, Prof Sherif; Elmonem , Prof Mohamed A.; Elmoselhi, Adel B.; Elnaem, Mohamed Hassan; Elsohaby, Ibrahim; Eltahir , Mohd Elmagzoub; Zeydi, Amir Emami; Emeto, Theophilus I.; Emran, Talha Bin; Eshraghi, Reza; Eskandari , Khalil; Eskandarieh, Sharareh; Eyawo, Oghenowede; Fabin , Natalia; Fadavian, Heidar; Fagbamigbe, Adeniyi Francis; Fahim, Ayesha; Fahimi, Saman; Fahira, Aamir; Faiz, Razana; Fakhradiyev, Ildar Ravisovich; Falzone, Luca; Fan, Qiping; Farahani, Alireza; Farahmand, Mohammad; Faraji, Seyed Nooreddin; Faramarzpour , Mahsa; Faraon, Emerito Jose Aquino; Fareed, Mohammad; Farina, Jacopo; Faris, Prof MoezAlIslam Ezzat Mahmoud; Faro , Andre; Farooq, Syed Muhammad Yousaf; Farooqui, Maryam; Farrokhpour, Hossein; Farshad, Fatemeh; Farsi, Farima; Fatima, Prof Zareen; Fazeli , Pooria; Feili , Afrooz; Feizkhah , Alireza; Fekadu, Ginenus; Feng, Xiaoqi; Fereshtehnejad, Seyed-Mohammad; Fernandez-Jimenez, Rodrigo; Feroze, Abdullah H.; Ferrara, Pietro; Ferreira , Prof Nuno; Feter, Natan; Feyisa , Bikila Regassa; Fiorilla, Claudio; Fischer, Florian; Fleszar, Laura; Flor, Luisa S.; Fogacci, Federica; Foigt, Nataliya A.; Fonzo, Marco; Fornari, Arianna; Fornari , Carla; Forray, Alina Ioana; Fortuna, Daniela; Foschi , Matteo; Fotouh, Maryam; Francis-Oliviero, Florence; Fukumoto, Takeshi; Fux, Prof Blima; Gaal , Prof Peter Andras; Gadeka, Dominic Dormenyo; Gafane-Matemane, Lebo Francina; Gaidhane, Prof Abhay Motiramji; Gaipov, Abduzhappar; Gajdács, Márió; Gakidou, Prof Emmanuela; Galali , Yaseen; Gallus , Silvano; Ganesan, Balasankar; Gangachannaiah , Shivaprakash; Gao, Prof Xiang; Garcia , Prof Fernando Barroga; Garcia-Azorin , Prof David; Garg, Prof Ravindra Kumar; Garg, Prof Vinod Kumar; Garlasco, Jacopo; Gasevic, Danijela; Gautam, Prem; Gautam, Prof Rupesh K.; Ge, Hong-Han; Gebre , Feven Sahle; Gebregergis, Miglas Welay; Gebremariam, Alemayehu Digssie Digssie; Gebremedhin, Amanuel Tesfay; Gebremichael, Bereket; Gelaw, Asmare Yitayeh; Geleta , Leta Adugna; Matin, Ali Gerami; Geremew, Gebremariam Wulie; Getahun, Genanew K.; Gete, Kalab Yigermal; Ghadimi, Delaram J.; Ghadirian, Fataneh; Ghaffari, Kazem; Ghaffari Jolfayi , Amir; Ghahramani , Sulmaz; Ghajar, Alireza; Ghamkhar, Arin; Gheshlagh, Reza Ghanei; Ghasemi Assl, Shakiba; Ghasemi Seproo, Faeze; Ghazy , Ramy Mohamed; Gheno, Gloria; Ghimire, Sailaja; Ghith, Nermin; Ghorbani, Zeinab; Gil, Artyom Urievich; Gilani, Syed Abdullah; Gilani, Prof Syed Amir; Gilbertson, Nora M.; Gill, Tiffany K.; Gillum, Richard F.; Girmay, Alem Abera; Girombelli 951 , 952; Glasstetter, Logan M.; Glushkova, Ekaterina Vladimirovna; Gnedovskaya, Elena V.; Göbölös, Prof Laszlo; Goel, Prof Amit; Goh, Lay Hoon; Gohari , Kimiya; Gohil, Megha Nishith; Goldust , Mohamad; Goleij, Pouya; Golinelli 964 965, 966; Golkar, Mohsen; Gomes-Neto, Prof Mansueto; MReza Goodarzian; Goshu, Tibebu Abel; Goulart, Prof Alessandra C.; Gregorio, Ernesto Ramos; Grivna, Prof Michal; Grover , Ashna; Guadie, Habtamu Alganeh; Guan, Shi-Yang; Guan, Zhongyang; Guarducci, Giovanni; Gubari, Mohammed Ibrahim Mohialdeen; Guha , Avirup; Guicciardi, Stefano; Gulati, Prof Sheffali; Gulati , Snigdha; Gunawardane , Damitha Asanga; Gunturu, Sasidhar; Guo, Qianyu; Guo, Xingzhi; Guo, Zheng; Guo, Zhifeng; Gupta, Anish Kumar; Gupta , Bhawna; Gupta, Himanshu; Gupta, Prof Lalit; Gupta, Rahul; Gupta, Prof Rajeev; Gupta, Sapna; Gupta, Prof Vivek Kumar; Gutiérrez-Murillo , Roberth Steven; Guzman-Esquivel, Jose; Habibzadeh, Adrina; Habibzadeh , Farrokh; Habteyes, Abrham Tesfaye Tesfaye; Habteyohannes , Awoke Derbie; Hadei, Mostafa; Hadi, Prof Najah R.; Hadian, Zahra; Haghdoost, Faraidoon; Haghmorad, Dariush; Haghtalab , Arian; Haile, Demewoz; Hailu, Haimanot Ewnetu; Haj-Mirzaian, Arvin; Pritam Halder, Pritam; Halim, Sobia Ahsan; Halwani, Prof Rabih; Hamad , Prof Islam M.; Hamdy, Prof Nadia M.; Hamidi, Prof Samer; Hamilton, Erin B.; Hammoud , Ahmad; Hamza , Mohammad; Hamza, Umar Sabiu; Hanif, Asif; Hanifi , Nasrin; Hankey, Prof Graeme J.; Hanna, Fahad; Haque , Moon Moon; Haque, Obaid I.; Hareru, Habtamu Endashaw; Haro, Josep Maria; Has, Eka Mishbahatul Marah; Hasaballah, Ahmed I.; Hasan, Faizul; Hasan , Md Kamrul; Hasani , Hamidreza; Hasanpour- Dehkordi, Prof Ali; Hashemian, Maryam; Hashempour , Zahra; PrHashempur, of Mohammad Hashem; Hashim, Nada Tawfig; Hasnain, Prof Md Saquib; Hassan, Prof Amr; Hassan, Ikrama Ibrahim; Hassan , Md Imtaiyaz; Hassan, Muhammad; Hassan, Shoaib; Hassan Wada, Yusuf Wada; Hassan Zadeh Tabatabaei, Mahgol Sadat; Hassankhani , Hadi; Haubold, Prof Johannes; Havmoeller, Rasmus J.; Hawat, Angie; Hay , Prof Simon I.; He, Guohua; He, Jiawei; He, Prof Qiang; Hebert, Prof Jeffrey J.; Heidari, Golnaz; Heidari , Mohammad; Heidari Gorji, Prof Mohammad Ali; Hemmati, Mehdi; Hesami , Hamed; Hewage, Sumudu Avanthi; Heydari, Majid; Heydari, Mojtaba; Hezam, Kamal; Hikibu, Mitiku Desalegn; Hiraike, Yuta; Holla, Ramesh; Hong , Young-Rock; Hopkins, Ashley Mark; Hoseinzadeh, Prof Mehdi; Hossain, Alamgir; Hossain , Lubna; Hossain, Md Belal; Hossain, Md Mahbub; Hossain, Md Sabbir; Hossain, Prof Mohammad Bellal; Hosseini mohammadi, Negin Sadat; Hosseinzadeh, Prof Hassan; Hostiuc, Mihaela; Hostiuc , Prof Sorin; Hotwani, Priya; Hoven, Hanno; Hsairi , Prof Mohamed; Hu , Ben; Hu , Chengxi; Huang, Junjie; Huang, Yu-Song; Huang , Prof Zunnan; Hundie , Tsegaye Gebreyes; Hushmandi, Kiavash; Hussain, Prof Javid; Hussain , Prof M Azhar; Hussein, Dursa; Husseiny, Prof Mohamed Ibrahim; Hwang , Prof Bing-Fang; Iavicoli , Prof Ivo; Ibitoye, Segun Emmanuel; Ibrahim, Khalid S.; Ibrahim, Ramzi; Ibrahim , Umar Idris; Ikeda, Nayu; Ikiroma, Adalia; Ilesanmi , Olayinka Stephen; Ilic, Irena M.; Ilic, Prof Milena D.; Ilyas , Muhana Fawwazy; Imam , Mohammad Tarique; Immurana, Mustapha; Imoh, Lucius Chidiebere; Inok, Arit; Iqhrammullah, Muhammad; Isa, Mustafa Alhaji; Iskandar , Benni; Iskander, Teresa R.; Islam, Md Fakrul; Islam, Md Rabiul; Islam, Md Sahidul; Islam, Md Saiful; Islam, Md Shariful; Islam, Rakibul M.; Ismail, Faisal; Ismail , Prof Nahlah Elkudssiah; Ismoldayev, Yerlan; Iso , Prof Hiroyasu; Isola, Prof Gaetano; Issa, Ramzy; Ituka, Mosimah Charles; Iwagami, Masao; Iyasu, Assefa N.; Jaafari, Jalil; Jacob, Louis; Jafari-Khounigh, Ali; Jaffar , Prof Shabbar; Jaganathan, Vennila; Jaganathasamy, Nagaraj; Jahan, Shafkat; Jahangiri , Soodeh; Jahani, Shima; Jahrami , Haitham; Jain , Akhil; Jain , Ayushi; Jain, Pragati; Jairoun, Ammar Abdulrahman; Jaiswal , Swati; Jakovljevic, Prof Mihajlo; Jaliliyan , Ali; Jalloh, Mohamed; Jamal, Armaan; Jamal, Qazi Mohammad Sajid; Jamali, Navid; Jameie, Melika; Jamshidi, Masoud; Janardhanan, Rajiv; Javadi , Nilofer; Javaid, Syed Sarmad; Javankiani , Sepide; Javanmardi, Anita; Jayanna, Prof Krishnamurthy; Jayapal, Sathish Kumar; Jayaram , Prof Shubha; Jayasinghe, Prof Ruwan Duminda; Jayatilleke , Achala Upendra; Jeong, Prof Seogsong; Jeswani , Bijay Mukesh; Jha, Anil K.; Ji , Zixiang; Jiang, Min; Jin, Wenyi; Jokar , Mohammad; Jonas, Prof Jost B.; Joo, Tamas; Jor, Abu; Jose, Jobin; Jose, Jobinse; Joseph, Nitin; Joshua, Charity Ehimwenma; Josten, Kripa; Joukar, Farahnaz; Jozwiak, Jacek Jerzy; Jürisson, Mikk; Juweid, Prof Malik E.; Kaambwa, Billingsley; Kabir , Ali; Kabir, Zubair; Kadashetti, Vidya; Kader, Avan; Kader, Md Lutful; Kadir, Prof Dler Hussein; Kaibullayeva, Jamilya; Kakkar , Ashish Kumar; Kalankesh, Leila R.; Kalra, Sanjay; Kamal, Prof Manoj; Kamarajah, Sivesh Kathir; Kamath, Ashwin; Kamel, Ibrahim; Kamireddy, Arun; Kamyari , Naser; Kamyshnyi, Prof Oleksandr; Kan, Prof Haidong; Kanaan, Prof Mona; Kanaan , Saddam Fuad; Kankam, Samuel Berchi; Kanmodi, Prof Kehinde Kazeem; Kansal , Prof Sushil Kumar; Kantar, Rami S.; Kar, Sujita Kumar; Karagiannidis, Efstratios; Karakasis , Paschalis; Karami, Jafar; Karch, André; Kariman, Arian; Karimi, Aliasghar; Karimtabar, Hajar; Karki, Prabin; Karobari , Prof Mohmed Isaqali; Karpiński, Prof Tomasz M.; Kasa, Ayele Semachew; Kasozi, Derrick; Kasraei , Hengameh; Kassa, Tigabu Hailu; Kassar, Ahmad M.; Kassebaum, Nicholas J.; Kattea, Mohammad Obadah; Kazemian , Sina; Kedir , Shemsu; Keivanlou, Mohammad-Hossein; Kelly, Jaimon Terence; Kempegowda, Swetha N.; Keshwani , Ariz; Kesse-Guyot, Emmanuelle; Keykhaei , Mohammad; Khadembashiri, Mohamad Mehdi; Khadembashiri, Mohammad Amin; Khademi , Reza; Khader, Prof Yousef Saleh; Khaing, Inn Kynn; Khajuria, Himanshu; Khaksar, Mohammad Ali; Khalid, Nauman; Khalil , Anees Ahmed; Khalili , Pantea; Khalis, Prof Mohamed; Khan, Ajmal; Khan, Asaduzzaman; Khan, Ullah; Khan, Fayaz; Khan, Iman Waheed; Khan , Maseer; Khan, Md Abdullah Saeed; Khan, Moien AB.; Khan, Muhammad Hamza; Khan , Muhammad Mueed; Khan, Muhammad Umer; Khan, Salman Ali; Khan, Serab; Khan, Sumaiya Khan; Khan, Ubaid; Khan, Yusuf Saleem; Khanal, Vishnu; Khashim , Zenith; Khatab, Prof Khaled; Khatatbeh, Prof Moawiah Mohammad; Khatib, Prof Mahalaqua Nazli; Khayat Kashani, Hamid Reza; Khazaei, Afshin; Kheirallah, Prof Khalid A.; Kheirandish Zarandi, Peyman; Kheradmand , Daniel; Khidri, Feriha Fatima; Khokhar, Manoj; Khokhar, Sunil Kumar; Khoshrou, Alireza; Khoshvaght, Parisa; Khosla, Atulya Aman; Khosravi , Ahmad; Khosravi, Majid; Khosravi , Sepehr; Khosrowjerdi, Mahmood; Khuman, P. Ratan; Kifle, Zemene Demelash; Kim, Prof Jinho; Kim , Prof Kwanghyun; Kim, Prof Sungroul; Kim, Yun Jin; Kimokoti, Ruth W.; Kinfu, Prof Yohannes; Kisa , Prof Adnan; Kisa, Sezer; Kivimäki, Prof Mika; KM, Prof Shivakumar; Kobyliak, Prof Nazarii; Kogi, Robert; Kohansal, Erfan; Kokkorakis , Michail; Kolahi, Ali-Asghar; Kolte, Dhaval; Kompani, Prof Farzad; Koohestani, Hamid Reza; Koren, Gerbrand; Kormoker, Tapos; Korshunov , Vladimir Andreevich; Korzh, Prof Oleksii; Koscik, Michal; Kostev, Prof Karel; Kothari, Prof Nikhil; Kothari, Yash Lalit; Kotnis, Ashwin Laxmikant; Koul, Prof Parvaiz A.; Koulmane Laxminarayana, Sindhura Lakshmi; Kretchy , James-Paul; Krishan, Prof Kewal; Krishna, Varun; Król , Zbigniew J.; Kua, Chong-Han; Kuchay, Raja Amir Hassan; Kucuk Bicer, Burcu; Kuddus, Prof Mohammed; Kukreti , Shikha; Kulimbet, Mukhtar; Kulkarni, Vishnutheertha; Kumar , Ashish; Kumar, Dewesh; Kumar , Anil; Kumar, Prof Kamal; Kumar, Manasi; Kumar , Mukesh; Kumar, Narendar; Kumar, Nithin; Kumar, Rakesh; Kumar, Tushar; Kumar , Vijay; Kundu, Amartya; Kunutsor, Prof Setor K.; Kurmi, Om P.; Kurniasari, Maria Dyah; Kusnali , Asep; Kustanti , Christina Yeni Yeni; Kusuma, Dian; Kuttybayev, Assylkhan; Kwong, Wai Hang Patrick; Kytö, Ville; L.C , Pallavi; La Vecchia, Prof Carlo; Lahariya, Chandrakant; Lai, Daphne Teck Ching; Lakanova, Balzhan; Lallukka, Prof Tea; Lám, Judit; Lanfranchi , Francesco; Lasrado, Savita; Latif , Areeba; Lau, Kenney Ki Lee; Lawal , Basira Kankia; Lawan, Aliyu; Le, Huyen Thi Thanh; Le, Thao Thi Thu; Le , Thoa; Le, Trang Diep Thanh; Le , Trang Thi Bich; Leasher, Janet L.; Lee, Prof Ivan; Lee, Paul H.; Lee , Prof Seung Won; Lee, Wei-Chen; Leivaditis, Vasileios; Leonardi, Matilde; Leong, Elvynna; Letafatkar, Negin; Li , An; Li , Daisong; Li, Jiaying; Li, Prof Jie; Li , Ming-Chieh; Li, Wei; Li, Weilong; Li, Wenjie; Li , Yichong; Li, Zhaolong Adrian; Li , Zhihui; Lim, Lee-Ling; Lim, Prof Stephen S.; Lin, Jialing; Lin, Queran; Lin, Ro-Ting; Lindholm , Daniel; Liu, Gang; Liu 1, Haipeng; Liu, Xiaofeng; Liu, Prof Xuefeng; Liu, Prof Zhe; Llanaj, Erand; Lohner, Valerie; Lonimath , Ashwini; López-Gil, José Francisco; Lopukhov, Platon D.; Lorenzovici , László; Lorkowski, Prof Stefan; Lotufo, Prof Paulo A.; Lourembam, Surbala Devi; Lucchetti , Prof Giancarlo; Lugo, Alessandra; Luo, Peng; Lutambi, Angelina M.; Lv, Hengliang; Lv, Lei; Lwin , Kaung Suu; Lytras, Dimitrios; Lytras, Prof Miltiadis D.; Lytvyak, Ellina; Ma, Kevin Sheng-Kai; Ma, Zheng Feei; Mabrok, Mahmoud; Machoy , Prof Monika; Madadi, Firoozeh; Madinezad, Seyed Ataollah; Madureira-Carvalho, Aurea Marilia; Maffia, Prof Pasquale; Gómez, Javier A. Magaña; Maghazachi, Prof Azzam A.; Mahalingam , Sasikumar; Mahalleh, Mehrdad; Mahalwar , Gauranga; Mahamed, Abdulahi Abdiwali; Mahamed, Samatar Abshir; Mahasha, Phetole Walter; Mahjoob, Monireh; Mahmood, Nozad Hussein; Mahmoudi , Elham; Mahmoudi , Farhad; Maiti, Prof Rituparna; Majmundar, Vidit D.; Malagón-Rojas, Jeadran N.; Malakan Rad, Prof Elaheh; Malekzadeh, Prof Reza; Malhotra , Prof Hardeep Singh; Malik, Prof Ahmad Azam; Malik , Muhammad Sajeel Ahmed; Malik, Shahid; Malik, Prof Tabarak; Malta, Prof Deborah Carvalho; Mangdow, Mustapha; Manirambona, Emery; Manjani, Lokesh; Manla, Yosef; Mannan, Fahmida; Mannethodi , Kamaruddeen; Mansoor, Farheen; Mansouri, Vahid; Mansourian, Prof Marjan; Mansournia, Mohammad Ali; Manu, Emmanuel; Maqsood, Prof Sajid; Marasini, Bishnu P.; Marateb, Hamid Reza; Marino , Mirko; Marks-Hultström, Michael; Marques, Prof Adilson; Martinez-Piedra, Ramon; Martins-Melo, Francisco Rogerlândio; Martorell, Miquel; März, Prof Winfried; Marzo , Prof Roy Rillera; Marzouk, Sammer; Masi, Prof Stefano; Masoudi, Alireza; Masrouri, Soroush; Matei, Clara N.; Mathangasinghe, Yasith; Mathew , Don; Mathur, Medha; Mathur, Neeta; Matozinhos , Prof Fernanda Penido; Mattiello, Rita; Mattoo, Khurshid A.; Maude, Prof Richard James; Maugeri, Andrea; Mazidi, Mohsen; Mazzaglia, Giampiero; McPhail, Prof Steven M.; Medel Salas, María Paz; Mehboob, Prof Riffat; Mehmood , Asim; Mehravar , Fatemeh; Mehrotra, Prof Ravi; Mehta, Prof Vini; Meto, Tesfahun Mekene; Mekonnen, Berhanu Abebaw; Mekonnen , Eskedar Getie; Meles, Hadush Negash; Melisa, Septi; Memish, Prof Ziad Ahmed; Mendoza, Walter; Menezes, Prof Godfred Antony; Menezes, Prof Ritesh G.; Mengesha, Endalkachew Worku; Mengistie, Emiru Ayalew; Mentis , Alexios-Fotios A.; Mercogliano, Michelangelo; Meretoja, Atte; Mestrovic, Tomislav; Mettananda, Prof Chamila Dinushi Kukulege; Mettananda, Prof Sachith; Metwally , Prof Mohamed; Miezah, Dennis; Miller, Ted R.; Minervini , Giuseppe; Ming, Prof Wai-kit; Mini , Prof G.K.; Mirdamadi, Arian; Mirdamadi, Niloofar; Mirghafourvand, Prof Mojgan; Mirrakhimov , Prof Erkin M.; Mirzaei, Roya; Mishra, Amaresh; Mishra, Archana; Mishra, Shivangi; Mishra, Vinaytosh; Mithra , Prasanna; Mittal, Chaitanya; Mobayen, Prof Mohammadreza; Modi , Natansh Deepak; Mogessie, Yidnek; Mohamed, Abdalla Z.; Mohamed, Ahmed Ismail; Mohamed, Heba M.; Mohamed, Hebatalla; Mohamed, Jama; Mohamed , Mona Gamal; Mohamed , Nouh Saad; Mohammad, Prof Ameen Mosa; Mohammad, Taj; Mohammad-Alizadeh-Charandabi, Prof Sakineh; Mohammadi , Abdolreza; Mohammadi, Ida; Mohammadi , Saeed; Mohammadi, Sammy; Mohammadi, Seyed Omid; Mohammadian-Hafshejani, Abdollah; Mohammadpour, Saeed; Mohammadzadeh, Ibrahim; Mohammed , Hussen; Mohammed, Prof Shafiu; Mohammed, Prof Yahaya; Mohan, Syam; Mohsen, Yazan; Mohsenzadeh, Amin; Mohsin , Aleenah; Mokdad, Prof Ali H.; Mokhirev, Alexandr; Molavi Vardanjani, Prof Hossein; Molinaro , Sabrina; Momani, Prof Shaher; Momeni, Hamidreza; Monasta, Lorenzo; Monazzami, Amirabbas; Moni , Mohammad Ali; Mons , Prof Ute; Namin , Sara Montazeri; Moradi , Tayebeh; Moraga, Paula; Morales-Juárez, Linda; Morawska, Prof Lidia; Moreira, Prof Rafael Silveira; Morgan, Anthony Kwame; Morovatdar, Negar; Morsy , Mahmoud M.; Morze, Jakub; Mossialos 1, Prof Elias; Motaharinezhad, Fatemeh; Motappa, Rohith; Motavvef, Maha; Motiei, Mahsa; Mousavi , Parsa; Mousavi Khaneghah, Prof Amin; Mousavi Kiasary, Seyed Mohamad Sadegh; Mowafy, Hagar; Mozafar , Mehrdad; MozafaryBazargany, Mohammadhossein; Mozahheb Yousefi, Kimia; Mubarik, Prof Sumaira; Muccioli, Lorenzo; Mueller, Prof Ulrich Otto; Mukherjee , Sumoni; Mukoro, George Duke; Mulatu, Sileshi; Mulita, Admir; Mulita, Francesk; Mulu, Getaneh Baye; Muneer, Muneeb Ahmad; Muniyandi , Malaisamy; Munjal, Kavita; Munkhsaikhan, Yanjinlkham; Munshi, Prof Anjana; Murillo-Zamora, Efren; Musa, Abbas; Musa, Sani; Mushtaq, Ali; Mustafa , Ahmad; Mustafa, Prof Ghulam; Muthu, Sathish; Muthupandian, Saravanan; Muvunyi , Prof Claude Mambo; Muzaffar, Muhammad; Mwita, Julius C.; Myung, Woojae; Nafei , Ayoub; Nagarajan, Ahamarshan Jayaraman; Naghavi, Pirouz; Naghshbandi, Mobin; Naik , Ganesh R.; Naik, Gurudatta; Naik, Hiten; Nainu, Prof Firzan; Nair, Prof Sanjeev; Najafi, Mohammad Sadeq; Najmuldeen, Hastyar Hama Rashid; Nakhostin Ansari, Prof Noureddin; Nambi , Prof Gopal; Nanavaty, Dhairya P.; Nangia, Vinay; Naqvi , Atta Abbas; Narasimha Swamy, Prof Sreenivas; Nargus, Shumaila; Nascimento, Prof Bruno Ramos; Nascimento, Gustavo G.; Naser , Mohammad; Nashwan, Abdulqadir J.; Nasrollahizadeh, Ali; Nasrollahizadeh, Amir; Nassar, Mahmoud; Natto, Zuhair S.; Nauman, Javaid; Naureen, Zakira; Navaratna , Samidi Nirasha Kumari; Nayak, Biswa Prakash; Nayak, Shalini Ganesh Ganesh; Nayon, Md Fahad Shahariar; Nchanji, G. Takop; Ndejjo, Rawlance; Ndungu, Anthony Wainaina; Neal , Prof Bruce; Nega, Amanuel Tebabal; Negahdary, Masoud; Negash, Wubshet D.; Negru, Alina Gabriela; Nejjari , Prof Chakib; Nekouei, Omid; Nematollahi , Mohammad Hadi; Nepal, Gaurav; Netsere , Henok Biresaw; Nezameslami , Ahmadreza; Ng, Marie; Ngunjiri , Josephine W.; Nguyen, Cuong Tat; Nguyen, Dang; Nguyen, Hau Thi Hien; Nguyen, Hien Quang; Nguyen , Kieu Viet Nhi; Nguyen, Long; Nguyen, The Phuong; Nguyen, Van Thanh; Niazi, Robina Khan; Nieddu, Luciano; Nikoobar, Ali; Nikravangolsefid, Nasrin; Niranjan , Vikram; Niroomand , Behnaz; Niyonsenga , Jean Marie Vianney; Nizam, Muhammad A.; Nkrumah-Boateng, Princess Afia Afia; Nnaji, Chukwudi A.; Nomura, Prof Shuhei; Noor, Syed Toukir Ahmed; Noormohammadpour, Pardis; Noreen , Mamoona; Noroozi, Masoud; Noubiap, Jean Jacques; Nouri, Mehran; Nriagu, Valentine C.; Nri-Ezedi, Chisom Adaobi; Ntsekhe, Prof Mpiko; Nugen, Fred; Nuh , Abdulkadir Mohamed; Nurchis, Mario Cesare; Nyadanu, Sylvester Dodzi Dodzi; Nyande, Felix Kwasi; Oancea, Prof Bogdan; Odat, Ramez M.; Oddi, Fabio Massimo; Odukoya , Oluwakemi Ololade; Oduro, Michael Safo; Oghenetega, Onome Bright; Ogundeko-Olugbami, Oluwafunmilayo Tosin; Oguta, James Odhiambo; Oh , Prof Sarah; O'Hagan, Edel T.; Ojedoyin, Olusegun Olatunji; Ojo-Akosile , Tolulope R.; Okati-Aliabad, Hassan; Okeke, Sylvester Reuben; Okekunle, Akinkunmi Paul; Okesanya, Olalekan John; Okonji, Osaretin Christabel; Okwute, Patrick Godwin; Olabisi , Oluwaseyi Isaiah; Olagunju, Prof Andrew T.; Olalusi, Oladotun Victor; Olanrewaju, Prof Timothy Olusegun; Olatubi, Matthew Idowu; Oliveira, Arão Belitardo; Oliveira , Prof Gláucia Maria Moraes; Olorukooba, Abdulhakeem Abayomi; Oludoye, Oluseye Olalekan; Olum, Ronald; Oluwole, Oluwafemi G.; Omage , Folorunsho Bright; Omer, Goran Latif; Omonisi , Abidemi E.; Ong, Sok King; Onyeaghala , Chizaram A.; Oommen, Prof Anu Mary; Opitz, Marcel; Ordak, Michal; Orscelik, Atakan; Ortiz, Prof Alberto; Ortiz-Prado , Prof Esteban; Osborne , Augustus; Osman, Alaa A.M.; Osman, Wael M.S.; Ostrominski, John W.; Osuagwu , Uchechukwu Levi; Othman, Elham H.; Otorkpa, Oche Joseph; Oumer , Abdu; Ouyahia, Prof Amel; Owolabi, Prof Mayowa O.; Owusu, Irene Amoakoh; Oyebanji, Oladayo Ayobami; Oyebola, Kolapo; Oyelade , Tope; P. A, Prof Mahesh; Padda, Inderbir; Padron-Monedero, Alicia; Padubidri , Prof Jagadish Rao; Palladino, Raffaele; Pan, Prof Hai-Feng; Panda, Sujogya Kumar; Panda-Jonas, Songhomitra; Pande Katare, Prof Deepshikha; Pandey, Ashok; Panelo, Carlo Irwin Able; Pang , Ke; Pani, Paola; Panigrahi , Sunil Kumar; Panos, Prof Georgios D.; Panos, Leonidas D.; Pant, Suman; Pantazopoulos, Prof Ioannis; Pantea Stoian, Prof Anca; Papadimopoulos , Ilias; Papadopoulou, Prof Paraskevi; Parekh, Utsav; Roudsari, Peyvand Parhizkar; Parikh, Romil R.; Park, Chulwoo; Park , Seoyeon; Parmar, Arpit Jashwantbhai; Parvandi, Ava; Pashaei, Ava; Passera, Roberto; Patel , Hemal M.; Patel , Jay; Patel, Riya Jayesh; Patel , Sangram Kishor; Patil, Prof Shankargouda; Patoulias, Prof Dimitrios; Pattnaik, Snigdha; Paudel , Deepak; Paudel, Susan; Pawar, Shrikant; Pawar, Shubhadarshini; Toroudi, Hamidreza Pazoki; Pedersini , Paolo; Pekarcikova, Jarmila; Pensato , Umberto; Pepito, Veincent Christian Filipino; Peprah, Emmanuel K.; Peprah, Prince; Pereira, Prof Gavin; Pereira, Prof Maria Odete; Perico, Norberto; Perna , Prof Simone; Peter, Olumuyiwa James; Pham , Hoang Nhat; Pham, Hoang Tran; Pham , Tung Thanh; Phillips, Prof Michael R.; Piradov, Prof Michael A.; Pirera, Edoardo; Pisoni, Enrico; Plotnikov , Evgenii; Poddighe, Prof Dimitri; Polibin , Roman V.; Pollner, Peter; Poluru, Ramesh; Pon Avudaiappan, Arjun; Porntaveetus , Thantrira; Pourbabaki, Reza; Pourghazi, Farzad; Pourkand , Donya; Poursadeqiyan, Prof Mohsen; Pourshams, Prof Akram; Prabhu, Prof Ravindra Attur; Pradhan , Prof Jalandhar; Pradhan, Pranil Man Singh; Prakash, Prem; Prakash, V.; Prasad, Ananya; Prashant , Prof Akila; Pribadi, Dimas Ria Angga; Purohit , Jyotirekha; Puvvula, Jagadeesh; Qanash, Husam; Qasim, Nameer Hashim; Qattea , Ibrahim; Qi , Xiang; Qi, Prof Zhipeng; Qian , Gangzhen; Qiu, Jia-Yong; Rabiee, Navid; Radhakrishnan, Prof Venkatraman; Radojčić, Maja R.; Radpour , Negar; Rafiei , Deniz; Raghuveer, Pracheth; Rahim, Prof Fakher; Rahim, Hawbash Mohammed-Amin; Rahimi , Mehran; Rahimian, Zahra; Rahimifard, Mahban; Rahman , Fryad Majeed; Rahman, Mohammad Hifz Ur; Rahman, Prof Mohammad Meshbahur; Rahman, Prof Mosiur; Rahman, Prof Muhammad Aziz; Rahmani, Amir Masoud; Rahmani , Saeed; Rahmanian, Nazanin; Rahmati , Prof Masoud; Rahmawaty , Setyaningrum; Rahmoune, Hakim; Rai, Pramila; Raina, Prof Sunil Kumar; Raj, Jeffrey Pradeep; Raja, Sandesh; Rajaa , Sathish; Rajabi , Erta; Rajendran, Gunaseelan; Rajendran, Judah; Rajendran, Vinoth; Rajpurohit, Siddheesh; Rajput , Prashant; Ramadan, Prof Mahmoud Mohammed; Ramadan, Majed; Ramadhan , Kadar; Ramasamy, Chitra; Ramasamy , Shakthi Kumaran; Ramírez-Vélez, Robinson; Ramphul, Kamleshun; Rana, Kritika; Rana, Rishabh Kumar; Ranabhat, Chhabi Lal; Rancic, Nemanja; Rao , Mithun; Rao, Sowmya J.; Rashedi , Sina; Rashedi, Vahid; Rashid, Mamunur; Rashidi, Mohammad-Mahdi; Rashidian, Pegah; Rasouli, Mohammad Aziz; Rasouli-Saravani, Ashkan; Rauniyar , Santosh Kumar; Rautalin, Ilari; Rawaf , David Laith; Rawaf , Prof Salman; Rawassizadeh, Reza; Rawlley, Bharat; Rayati , Mohammad; Razo, Christian; Rebelo, Artur; Reddy, Murali Mohan Rama Krishna; Redwan , Prof Elrashdy; Rege, Sanika; Rehman, Aqeeb Ur; Rehman, Wajiha; Reifels, Lennart; Reis-Mendes, Ana; Remuzzi , Prof Giuseppe; Rengasamy, Prof Kannan RR.; Rezaei, Nazila; Rezaeian, Prof Mohsen; Rezazadeh Eidgahi , Donya; Rhee , Taeho Gregory; Rias , Yohanes Andy; Riaz, Mavra A.; Ribeiro, Prof Antonio Luiz P.; Rizvi, Prof Moattar Raza; Rocha, Prof Hermano Alexandre Lima; Rocha-Gomes, João Rocha; Rodrigues da Silva, Thales Philipe; Rodriguez , Prof Jefferson Antonio Buendia; Roever, Prof Leonardo; Rojas-Rueda , Prof David; Romadlon, Debby Syahru; Ronfani, Luca; Rong , Jian; Roshandel, Gholamreza; Roshanshad, Amirhossein; Rotimi, Kunle; Rout, Prof Himanshu Sekhar; Rouzbahani, Shiva; Roy, Adrija; Roy, Bedanta; Roy, Nitai; Roy, Poulami; Roy, Sharmistha; Roy, Shubhanjali; Roy, Simanta; Russo, Michele; Rwegerera, Godfrey M.; S. N, Chandan; Saad Eddin, Adnan; Saadatian , Zahra; Saber, Korosh; Saber-Ayad, Prof Maha Mohamed; Sabet , Cameron John; Sabour , Prof Siamak; Sachdev, Prof Perminder S.; Sachdeva, Rajesh; Sadarangani, Prof Kabir P.; Saddik, Prof Basema Ahmad; Sadee, Bashdar Abuzed; Sadegh , Tarannom; Sadeghi-Ghyassi, Fatemeh; Saeed, Prof Umar; Safari , Mehdi; Sagar, Prof Rajesh; Saghafi , Alireza; Saghazadeh, Amene; Sagoe, Prof Dominic; Saha, Nondo; Saheb Sharif-Askari , Fatemeh; Saheb Sharif-Askari, Narjes; Sahebkar, Prof Amirhossein; Sahiledengle, Biniyam; Sahoo, Pragyan Monalisa; Sahu, Kirti Sundar; Sahu, Monalisha; Sajadi , Prof S Mohammad; Sajib, Md Refat Uz Zaman; Sajid, Mirza Rizwan; Salabat, Dorsa; Salami, Afeez Abolarinwa; Salarabedi, Mohammad-Mahdi; Salau, Ibrahim Layi; Saleh, Prof Mohamed A.; Salehi , Mahdi; Salehi , Sana; Salehi, Sara; Salehi Omran, Hossein; Salem, Marwa Rashad; Salem, Prof Mohammed Z. Y; Salimi, Sohrab; Samadzadeh, Sara; Samargandy , Saad; Samimisedeh, Parham; Samodra, Yoseph Leonardo; Samuel, Nahom Samuel; Samuel, Prof Vijaya Paul; Samy, Abdallah M.; Sanabria, Prof Juan; Sangle , Sandeep G.; Sanjari, Elaheh; Sanjeev, Prof Rama Krishna; Santos, Itamar S.; Santos, Lucas H.C.C.; Santric-Milicevic, Prof Milena M.; Sao Jose , Bruno Piassi; Sapkota, Krishna Prasad; Sarami, Marjan; Sarasmita, Made Ary; Saravanan , Aswini; Saravi, Babak; Sarikhani, Mahshad; Sarikhani , Yaser; Sarkar, Tanmay; Sarlak, Hamid; Sarma, Hemen; Sarmadi , Mohammad; Sarode, Prof Gargi Sachin; Sarode, Prof Sachin C.; Sarrafzadegan, Prof Nizal; Sassano, Michele; Sathian, Brijesh; Sathya Narayanan, Mukesh Kumar; Satpathy , Prof Maheswar; Sattarpour, Reza; Saulam, Jennifer; Savabi Far , Mehrdad; Saxena, Sangeeta Gopal; Saya, Ganesh Kumar; Sayeed, Abu; Schaarschmidt , Prof Benedikt Michael; Schinckus, Prof Christophe; Schmidt , Prof Maria Inês; Schuermans, Art; Schumacher, Austin E.; Schutte, Prof Aletta Elisabeth; Schwebel, David C.; Schwendicke, Prof Falk; Sebastian, Sneha Annie; Seboka, Binyam Tariku; Semreen , Prof Mohammad H.; Sendekie, Ashenafi Kibret; Sengupta , Pallav; Senol , Yigit Can; Senthilkumaran, Subramanian; Sepanlou, Sadaf G.; Serban, Prof Andreea Claudia; Serban, Dragos; Sethi , Yashendra; Sewor , Christian; Seyed Alshohadaei, Seyed Mohammad; Seylani , Allen; Seyoum, Abebaw B.; Sha'aban , Abubakar; Shafie, Mahan; Shahab, Muhammad; Shaharudin, Shazlin; Shahid , Izza; Shahid, Samiah; Shahid, Syed Ahsan Ahsan; Shahid, Wajeehah; Shahkarami, Farshad; Shahrahmani, Fatemeh; Shahsavari, Hamid R.; Shahwan, Prof Moyad Jamal; Shaikh , Masood Ali; Shaikh, Nafhat; Shamim, Muhammad Aaqib; Shams-Beyranvand, Mehran; Shamshad, Hina; Shamsi, Anas; Shamsutdinova, Alfiya; Shan, Dan; Shanawaz , Mohd; Shanmugasundaram , Devika; Sharath , Medha; Sharew, Nigussie Tadesse; Sharif, Muhammad Junaid Hassan; Sharifan , Amin; Sharma, Avimanu; Sharma, Bunty; Sharma, Prof Kamal; Sharma, Prof Manoj; Sharma, Ujjawal; Sharma, Vishal; Shastry, Prof Shamee; Shawahna, Prof Ramzi; Shawel, Samrawit; Shayan, Amir Mehdi; Bappah, Babangida Shehu; Sheida, Fateme; Sheidaei, Ali; Shekhar, Shashank; Shen, Jiabin; Shenoy, Rekha Raghuveer; Shetty, Pavanchand H.; Shi, Hui-Zhong; Shi , Wenming; Shibuya, Prof Kenji; Shiferaw, Desalegn; Shimaponda-Mataa, Nzooma Munkwangu; Shimels , Tariku; Shimul , Md Monir Hossain; Shin, Prof Min-Jeong; Shiri, Rahman; Shittu, Aminu; Shivarov, Velizar; Shlobin, Nathan A.; Shoaib, Ambreen; Shojaie , Shima; Shokati Eshkiki, Zahra; Shool, Sina; Shorofi, Seyed Afshin; Shrestha, Sunil; Shuval, Prof Kerem; Si, Lei; Si , Yafei; Sibuyi, Nicole R.S.; Siddig, Emmanuel Edwar; Siddiqi, Ahmed Kamal; Sidiq, Mohammad; Siegel , Prof Martin; Sikdar , Mithun; Silva, Prof Luís Manuel Lopes Rodrigues; Simegn, Gizeaddis Lamesgin; Simkhada, Prof Padam Prasad; Singh, Prof Abhinav; Singh, Ambrish; Singh , Baljinder; Singh , Prof Bhim Pratap; Singh, Harmanjit; Singh, Harpreet; Singh, Prof Jasvinder A.; Singh, Lucky; Singh, Paramdeep; Singh , Poornima Suryanath; Singh, Puneetpal; Singh, Surendra; Singh, Surjit; Sinha , Mukesh Kumar; Sinha, Ratnesh; Sivaramakrishnan, Gowri; Siwal, Samarjeet Singh; Skhvitaridze, Prof Natia; Sleet, Prof David A.; Sliwa, Prof Karen; Sohal , Aalam; Sohrabi , Somaye; Sokhal , Balamrit Singh; Solanki, Shipra; Solikhah, Prof Solikhah; Soliman, Ahmed M.; Soliman, Sameh S.M.; Howyzeh, Mehdi Soltani; Song, Prof Weiyi; Soni , Mansi; Soni, Suha; Sood, Aayushi; Sood , Prashant; Soraneh, Soroush; Soriano, Prof Joan B.; Sorrentino, Michele; Sousa, Marco Aurelio; Souza, Tamires C.M.; Soyiri , Ireneous N.; Spartalis , Michael; Spearman, Sandra; Sreeramareddy, Prof Chandrashekhar T.; Srichawla, Bahadar S.; Srinivasamurthy, Suresh Kumar; Stachteas, Panagiotis; Stafford, Lauryn K.; Stanaway , Jeffrey D.; Stanikzai, Muhammad Haroon; Starodubova , Antonina V.; Steckling-Muschack , Prof Nadine; Steiropoulos, Paschalis; Stephan, Prof Blossom Christa Maree; Stevanović, Aleksandar; Stockfelt, Leo; Stortecky, Stefan; Stubbs, Peter; Subedi , Narayan; Sukaew, Thitiporn; Sulaiman, Surajo Kamilu Kamilu; Suleiman, Auwal Garba; Suleiman Odidi, Muritala Odidi; Suleman, Muhammad; Sulistiyorini , Desy; Sullman, Prof Mark J.M.; Sultan Meo , Anusha; Sun, Prof Jing; Sun , Xiaohui; Sun, Zhong; Sundaram, Shanthosh Priyan; Sundström , Prof Johan; Sunny, Sumam; Sunuwar, Dev Ram; Susianti, Hani; Swain , Chandan Kumar; Swami Vetha, Berwin Singh; Szarpak, Prof Lukasz; Tabaee Damavandi, Payam; Tabarés-Seisdedos, Prof Rafael; Tabatabaei, Seyyed Mohammad; Tabche , Celine; Tabish, Mohammad; Tabuchi, Takahiro; Tadesse, Getu Ferenji; Tafida, Buhari Abdullahi; Tahmasbi Arashlow, Farzin; Taiba, Jabeen; Tajabadi , Shima; Takele, Wubet Worku; Talaat, Prof Iman M.; Talic, Stella; Tampa, Mircea; Tamuzi , Jacques Lukenze; Tanashat, Mohammad; Tang , Haosu; Tantisattamo, Ekamol; Tarekegn , Gebrekidan Ewnetu; Tariq, Saba; Tavakoli, Kiarash; Tavangar, Prof Seyed Mohammad; Tavasol , Arian; Tekola, Abainash; Temesgen, Worku Animaw; Temsah, Prof Mohamad-Hani; Teramoto , Masayuki; Tewari, Jay; Teye-Kwadjo, Enoch; Teymourzadeh, Azin; Thankappan , Prof Kavumpurathu Raman; Thapa, Rajshree; Thapar , Rekha; Thavamani, Aravind; Thayumana Sundaram, Mahalakshmi; Thiruvengadam , Prof Muthu; Thomas, Prof Joe; Tian, Wei; Ticoalu, Jansje Henny Vera; Tilakaratne, Pramitha Gishan; Tiwari, Krishna; Tleshev, Madi; Tomo , Sojit; Tonelli, Prof Marcello; Topor-Madry, Roman; Touvier, Mathilde; Tovani-Palone, Marcos Roberto; Trabelsi, Khaled; Tran, Nghia Minh; Tran, Ngoc Ha; Tran , Quynh Thuy Huong; Tran, Tam Quoc Minh; Tran, Thang Huu; Tran Minh Duc, Nguyen; Trico, Domenico; Trihandini, Prof Indang; Tripathi, Prof Manjari; Tripathi, Tulika; Tripathy , Jaya Prasad; Tromans, Samuel Joseph; Truong , Quynh Xuan Nguyen; Truyen, Thien Tan Tri Tai; Tsai, Daniel Hsiang-Te; Tse, Prof Gary; Tsermpini, Evangelia Eirini; Tuglo, Lawrence Sena; Tumkur Narayanappa , Santhosh Kumar; Tumurkhuu, Munkhtuya; Tusa, Biruk Shalmeno; Tye , Sok Cin; Tyrovolas , Stefanos; Udoakang, Aniefiok John; Ulhaq, Inam; Ullah, Atta; Ullah, Saeed; Ullah , Shahid; Umair, Prof Muhammad; Umar , Hauwa Onozasi Onozasi; Umar, Lawan; Umar, Muhammad; Unim, Brigid; Unnikrishnan, Prof Bhaskaran; Upadhya, Dinesh; Upadhyay , Era; Uppal , Dipan; Urmey, Jeba Mahiad; Urso, Daniele; Usman, Jibrin Sammani; Ussai , Silvia; Ustunsoz, Damla; Uzun Ozsahin , Prof Dilber; Uzunçıbuk, Hande; Uzzaman, Nazim; Vadagam, Pratyusha; Vahdati, Sanaz; Vaithinathan, Asokan Govindaraj; Vakilian , Alireza; Vakilpour, Azin; Valizadeh , Gelareh; Van Daalen, Kim Robin; Van den Eynde, Jef; Varghese, Joe; Varma , Ravi Prasad; Varthya, Shoban Babu; Varughese, Prof Santosh; Vasankari, Prof Tommi Juhani; Vasudevan , Srivatsa Surya; Vellingiri, Balachandar; Venketasubramanian, Prof Narayanaswamy; Venkidasamy , Baskar; Verras, Georgios-Ioannis; Vervoort, Dominique; Vijayageetha , Mathavaswami; Villafañe, Jorge Hugo; Villani , Prof Leonardo; Vipparthy, Sharath Chaitanya; Vishwakarma, Mukesh; Vlassov, Prof Vasily; Volovat , Simona Ruxandra; Vosoughi, Mehdi; Vounzoulaki , Elpida; Vujcic , Isidora S.; Wada, Abubakar Sadiq; Wadhwa , Medha; Wafula, Solomon T.; Waheed, Prof Yasir; Wahidin , Mugi; Wahiduzzaman , Mohammad; Wahood, Samer; Wan, Prof Jin-Yi; Wang, Kongjia; Wang, Prof Liang; Wang, Minmin; Wang , Nelson; Wang, Shu; Wang, Prof Wei; Wang, Prof Yanzhong; Wang, Yuan-Pang; Wanjau, Mary Njeri; Waqar , Prof Ahmed Bilal; Waqas, Muhammad; Wassie, Gizachew Tadesse; Weerakoon, Prof Kosala Gayan; Weerasekara, Ishanka; Weintraub, Prof Robert G.; Westerman , Ronny; Wiangkham , Taweewat; Wibowo, Yohanes Cakrapradipta; Wicaksana, Anggi Lukman; Wickramasinghe , Dakshitha Praneeth; Wickramasinghe, Nuwan Darshana Darshana; Wijarnpreecha, Karn; Wijayanto , Matthew Aldo; Wilandika, Angga; Willeit, Prof Peter; Wireko, Andrew Awuah; Wirtu, Gemechu Kumera; Wojewodzic, Marcin W.; Wojtyniak, Bogdan; Wonde , Tewodros Eshete; Wondmeneh, Yohannes Chemere; Wongnaah, Florence Gyembuzie; Worku, Minichil Chanie Chanie; Wu, Prof Felicia; Wu , James Fan; Wu, Jiayuan; Wu, Junhui; Wu , Prof Zenghong; Wubie, Yihun Miskir Miskir; Xiao, Lishun; Xie, Prof Wanqing; Xu, Site; Xu, Wanqing; Xu, Xiaoyue; Xue , Mingyang; Yadav, Vikas; Yadollahi , Mahnaz; Yaghoubi , Sajad; Yahoo (Syed), Saba; Yahya, Galal; Yang, Xinxin; Yano, Yuichiro; Yao , Prof Haiqiang; Yao, Laiang; Yarahmadi, Amir; Yaregal Melesse, Debas; Yasufuku, Yuichi; Yavari, Mohammadjavad; Yaya, Prof Sanni; Yayeh , Melesse Belayneh; Ye, Pengpeng; Yeganeh, Meghdad; Yekdeş, Ali Cem; Yesodharan, Renjulal; Yesuf, Subah Abderehim; Yezengaw , Telksew Yelma; Yezli, Saber; Yi, Prof Siyan; Yin, Dehui; Yon, Prof Dong Keon; Yonemoto, Prof Naohiro; Youm , Prof Yoosik; Yousefi, Prof Zabihollah; Yousefzadeh-Chabok, Prof Shahrokh; Yu, Prof Chuanhua; Yu, Hairui; Yu, Prof Yong; Yuce , Deniz; Yunusa, Ismaeel; Yunusa, Umar; Zaghampour, Manijeh; Abidin, Emilia Zainal; Zairov, Dilmurat; Zakham, Fathiah; Zamagni, Giulia; Zanghì , Aurora; Zare, Iman; Zaresharifi, Shirin; Zarinfar , Yasaman; Zastrozhin, Prof Michael; Zawiah , Mohammed; Zazouli , Prof Mohammad Ali; Zeariya, Mohammed G.M.; Zemariam, Alemu Birara Birara; Zensen, Sebastian; Zhan , Tiansong; Zhang, Casper J.P.; Zhang , Haijun; Zhang, Prof Jinpeng; Zhang, Lin; Zhang, Liqun; Zhang, Xiaoyi; Zhang , Yunquan; Zhang, Zhiqiang; Zhao, Hanqing; Zhao, Zhenping; Zheng, David X.; Zheng, Jinxin; Zheng, Prof Ming-Hua; Zhong , Anthony; Zhou, Jiayan; Zhou, Juexiao; Zhou, Shuduo; Zhou, Xianghong; Zhou, Xiao-Dong; Zhu, Bin; Zhu, Wei; Zhumagaliuly , Abzal; Ziegelmayer, Sebastian; Zielińska, Magdalena; Zoghi, Ghazal; Zoromba, Mohamed Ali Ali; Zou, Prof Zhiyong; Zuber, Mohammed; Zyoud , Prof Ahed H.; Zyoud, Prof Sa'ed H.; Zyoud, Shaher H.; Murray, Prof Christopher J. L.; Mensah, George A.; Roth, Gregory A. (Elsevier, 2025-12-02)
    BACKGROUND : Cardiovascular diseases (CVDs) are the leading cause of mortality and are among the foremost causes of disability globally. CVD burden has continued to increase in most countries since 1990, with trends driven by changing exposures to harmful risk factors, population growth, and population aging. OBJECTIVES : We report estimates of global, national, and subnational CVD burden, including 18 subdiseases and 12 associated modifiable risk factors. We analyzed change in CVD burden from 1990 to 2023 and identified drivers of change including population growth, population aging, and risk factor exposure. METHODS : The Global Burden of Disease (GBD) 2023 study, a multinational collaborative research study, quantified burden due to 375 diseases including CVD burden and identified drivers of change from 1990 to 2023 using all available data and statistical models. GBD 2023 estimated the population-level burden of diseases in 204 countries and territories from 1990 to 2023. RESULTS : CVDs were the leading cause of disability-adjusted life years (DALYs) and deaths estimated in the GBD. As of 2023, there were 437 million (95% UI: 401 to 465 million) CVD DALYs globally, a 1.4-fold increase from the number in 1990 of 320 million (292 to 344 million). Ischemic heart disease, intracerebral hemorrhage, ischemic stroke, and hypertensive heart disease were the leading cardiovascular causes of DALYs in 2023 globally. As of 2023, agestandardized CVD DALY rates were highest in low and low-middle Socio-demographic Index (SDI) settings and lowest in high SDI settings. The number of CVD deaths increased globally from 13.1 million (95% UI: 12.2 to 14.0 million) in 1990 to 19.2 million (95% UI: 17.4 to 20.4 million) in 2023. The number of prevalent cases of CVD more than doubled since 1990, with 311 million (95% UI: 294 to 333 million) prevalent cases of CVD in 1990 and 626 million (95% UI: 591 to 672 million) prevalent cases in 2023 globally. A total of 79.6% (95% UI: 75.7% to 82.5%) of CVD burden is attributable to modifiable risk factors 347 million [95% UI: 318 to 373 million] DALYs in 2023). Globally, high systolic blood pressure, dietary risks, high low-density lipoprotein cholesterol, and air pollution were the modifiable risks responsible for most attributable CVD burden in 2023. Since 1990, changes in exposure to modifiable risk factors have had mixed effects on CVD burden, with increases in high body mass index, high fasting plasma glucose, and low physical activity leading to higher burden, while reductions in tobacco usage have mitigated some of these increases. Population growth and population aging were the main drivers of the increasing burden since 1990, adding 128 million (95% UI: 115 to 139 million) and 139 million (95% UI: 126 to 151 million) CVD DALYs to the increase in CVD burden since 1990. CONCLUSIONS : CVD remains the leading cause of disease burden and death worldwide with the greatest burden in low, low-middle, and middle SDI regions. Large variation exists in CVD burden even for countries at similar levels of development, a gap explained substantially by known, modifiable risk factors that are inadequately controlled. The decades-long increase in CVD burden was the result of population growth, population aging, and increased exposure to a subset of risk factors led by metabolic risks. Countries will need to adopt effective health system and public health strategies if they are to progress in achieving global goals to reduce the burden of CVD.
  • Item
    Coagulation is associated with renal function decline and chronic kidney disease in people living with HIV in South Africa
    Choshi, Joel; Mokoena, Haskly; Mabhida, Sihle E.; Flepisi, Brian T.; Steel, Helen Carolyn; Mokgalaboni, Kabelo; Phoswa, Wendy N.; Maarman, Gerald; Nkambule, Bongani B.; Dludla, Phiwayinkosi V.; Hanser, Sidney (Frontiers Media, 2026-05-22)
    BACKGROUND : Chronic inflammation is a well-documented feature of human immunodeficiency virus (HIV) infection and is implicated in the progression of several comorbidities, including chronic kidney disease (CKD). Notably, chronic coagulation activation is another common phenomenon mediated by chronic inflammation among people living with HIV (PLWH) and has also been linked to CKD progression. However, the relationship between inflammation, coagulation and renal dysfunction remains underexplored in African populations with high HIV prevalence. This study investigated the association between systemic inflammation, coagulation activation and renal function among PLWH, particularly those receiving antiretroviral therapy (ART). METHODS : In this cross-sectional study, 151 adults were enrolled, comprising 80 PLWH on ART, 27 PLWH not on ART, and 44 people not living with HIV (PNLWH). Inflammatory marker, C-reactive protein (CRP) and coagulation markers including fibrinogen and D-dimer, were measured and CKD stages were determined using estimated glomerular filtration rate (eGFR), which was calculated based on cystatin C (cystC) levels (eGFRcystC). RESULTS : In the overall PLWH cohort, D-dimer was significantly associated with reduced eGFRcystC in both crude (p = 0.004) and adjusted analyses (p = 0.014), indicating poorer kidney function. Fibrinogen showed a significant association with reduced eGFRcystC only after adjusting for confounders (p = 0.048). Among PLWH on ART, D-dimer remained independently associated with reduced eGFRcystC, while fibrinogen showed an independent association after adjustment (β = -1.54, p = 0.031). Elevated fibrinogen levels were associated with an increased odds of CKD in the overall PLWH group (AOR = 1.12, 95% CI 1.00-1.23, p = 0.0 41), and elevated D-dimer levels were associated with increased odds of CKD among those on ART (AOR = 1.01, 95% CI 1.00-1.03, p = 0.045). CONCLUSION : The study reveals that both D-dimer and fibrinogen, key markers of coagulation are independently associated with renal function decline and risk of CKD in PLWH, particularly those on ART. These findings suggest that coagulation activation may be an early indicator of declining kidney function and increased risk of CKD in PLWH, potentially preceding overt systemic inflammation.
  • Item
    Bayesian inference of haematopoietic stem/progenitor cell differentiation phenotypic manifolds and their bifurcation points using Gaussian processes and Gibbs sampling
    Dowling, Riaan Deon; Mellet, Juanitah; Wolmarans, Elize; Durandt, Chrisna; Joubert, Fourie; De Villiers, Johan Pieter; Pepper, Michael Sean (Nature Research, 2026-05-26)
    Cell differentiation is a fundamental biological process, where cells progress through different stages of maturation to become specialised cell types. Understanding this process is important, and has led to the development of various mathematical models to represent cell behaviour during maturation. Advancements in these models are owed to researchers’ ability to obtain high-throughput genome-scale single-cell gene expression data, which has revolutionised our understanding of complex processes like haematopoiesis. Here we introduce BAGEL: Bayesian Analysis of Gene Expression Lineages, a novel statistical model. BAGEL offers new insights into cell differentiation through (i) a robust Bayesian inference approach that models cell differentiation as a continuous process; and (ii) a powerful projection method that enables visualisation and investigation of similarities and differences between intra- and inter-species single-cell gene expression datasets. The ability of BAGEL’s projection method to harness the collective power of multiple datasets is enormous as it can potentially accelerate and enhance our understanding of cell differentiation. Although this manuscript focuses on haematopoiesis, BAGEL should apply to various single-cell gene expression datasets, providing a deeper understanding of cellular complexity.
  • Item
    Immune checkpoint inhibitors and cutaneous adverse events in oncologyc treatment : a case report and review of immune-related mechanisms and management
    Teixeira, Miguel J.; Thoresen, Jason; Steel, Helen Carolyn; Rossouw, Theresa M. (Allergy Society of South Africa, 2026-09-01)
    Immune checkpoint inhibitors (ICIs) have transformed oncology treatment by enhancing T-cell-mediated anti-tumour immunity through the inhibition of key immune checkpoint regulators. These regulators include cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) and the programmed cell death protein-1 (PD-1)/programmed death ligand-1 (PD-L1) axis. By modulating immune checkpoint signalling, these agents enhance adaptive T-cell responses and can also amplify broader immune activity involving innate and peripheral immune compartments. Despite their clinical benefits, ICIs are associated with a spectrum of immune-related adverse events (irAEs) that result from iatrogenic immune dysregulation. We report the case of a 76-year-old man who developed pruritic dermatitis during immunotherapy, with accompanying significant effects on his sleep and quality of life (QoL). This case illustrates the clinical burden of cutaneous irAEs and emphasises the importance of individualised management approaches. The effective management of these adverse events is critical to maintaining the continuity of immunotherapy while preserving the patient's QoL.
  • Item
    Triple-negative breast cancer : molecular subtypes; immune escape; limitations of current immunotherapy; and the BTLA/HVEM/CD160 axis as an emerging target
    Rapoport, Bernardo Leon; Anderson, Ronald; Van Tonder, Daniel; Smit, Teresa; Rossouw, Theresa M.; Benn, Carol-Ann; Steel, Helen Carolyn (MDPI, 2026)
    Triple-negative breast cancer is an aggressive and heterogeneous type of invasive breast cancer (BC) in which the cancer cells lack estrogen and progesterone receptors, as well as expression of the human epidermal growth factor 2 protein. This cancer tends to grow and spread faster than other BC subtypes, and is associated with a poor prognosis due to early visceral and neurological recurrences. Multidisciplinary management includes surgery, chemotherapy, radiation therapy, and immunotherapy with targeted immune checkpoint inhibitors (ICIs). The introduction of ICIs has improved outcomes in patients with TNBC, particularly in the metastatic and neoadjuvant settings. Despite these advances, a significant proportion of patients either do not respond to treatment or develop resistance to it. TNBC mortality remains high, underscoring the urgent need to identify novel prognostic and predictive biomarkers to overcome resistance to immunotherapy. Following a brief overview of the clinical features and established biomarkers of TNBC, the current review focuses on immune checkpoint proteins (ICPs) beyond PD-1 and PD-L1, and on the potential use of soluble ICPs rather than the well-established membrane-bound assays. These soluble ICPs are produced through the alternative splicing of messenger (m)RNA or the cleavage/shedding of membrane-bound proteins. This is followed by an overview of current treatment and novel predictive targets in TNBC. Additionally, the involvement of the B- and T-lymphocyte attenuator (BTLA)/herpes virus entry mediator (HVEM)/CD160 pathway and its role in the pathogenesis of BC and TNBC are reviewed, highlighting the potential use of BTLA and HVEM as biomarkers.
  • Item
    Distinct patterns of clinical features and cardiac biomarker elevation in community-acquired pneumonia and COVID-19 pneumonia
    Mukansi, Murimisi; Steel, Helen Carolyn; Rossouw, Theresa M.; Kalla, Ismail; Menezes, Colin; Nieuwoudt, Martin; Anderson, Ronald; Feldman, Charles (MDPI, 2026-07)
    No previous sub-Saharan studies have compared patients with community-acquired pneumonia (CAP) and COVID-19 pneumonia, the focus of this study. Consecutive adult patients hospitalized with CAP (n = 59) or COVID-19 pneumonia (n = 74) were compared regarding multiple characteristics, including cardiac biomarkers. In multivariable logistic regression analysis, differences were noted among various clinical features. Troponin I concentrations (p = 0.00028) and the Troponin I/NT-pro BNP ratio (p = 0.00048) were significantly higher in COVID-19 compared with CAP. After adjustment for age, these differences remained significant (troponin I p = 0.0019; ratio p = 0.00054), while BNP concentrations were now higher in CAP (p = 0.009). PCA demonstrated that BNP and NT-pro BNP contributed most strongly to the dominant cardiac biomarker signature, suggesting shared cardiopulmonary stress across both diseases. Exploratory subgroup analyses suggested higher troponin I levels among people living with HIV and COVID-19, although interaction modelling did not demonstrate significant effect modification by HIV status. Both CAP and COVID-19 pneumonia were associated with evidence of cardiac stress; however, COVID-19 demonstrated a relatively stronger myocardial injury signature characterized by higher troponin I concentrations and an increased Troponin I/NT-pro BNP ratio while CAP had evidence of greater hemodynamic cardiac strain, as evidenced by the higher levels of BNP. The findings suggest that the mechanisms of cardiac involvement may differ between viral and bacterial respiratory infections.
  • Item
    Systemic protein biomarkers, composite blood inflammatory indices and cellular ratios in metastatic colorectal cancer : potential therapeutic targets
    Smit, Teresa; Anderson, Ronald; Steel, Helen Carolyn; Rossouw, Theresa M.; Rapoport, Bernardo Leon (MDPI, 2026-04-27)
    BACKGROUND/OBJECTIVES : Although informative, current insights into the inflammatory nature of colorectal cancer (CRC) have yet to have a meaningful impact on the prevention of, and development of novel therapies for, the treatment of this prevalent and challenging disease. Accordingly, the current study was focused on identifying putative, key, systemic, mostly pro-inflammatory biomarkers of metastatic CRC (mCRC) prognosis and outcome. METHODS : Patients with mCRC (n = 38) and matched healthy controls (n = 30) were recruited to the study. A multiplex magnetic bead array system and an ELISA procedure were used to measure the plasma concentrations of selected cytokines (n = 25) and that of C-reactive protein (CRP) by immunonephelometry. Systemic inflammatory indices (n = 5) were derived from the hematological data. RESULTS : Plasma levels of 17/25 of the cytokine biomarkers and CRP were found to be significantly elevated, while the neutrophil/lymphocyte ratio proved to be the most useful of the various inflammatory indices. Subgroup analysis of the data derived from the group of mCRC patients revealed that the intensity of the systemic inflammatory response was mostly unaffected by tumor location, age, gender, and treatment line. The exception was time to progression, with a shorter time (<120 days) being associated with increased levels of IL-6, IL-8 and TNF-α. Hierarchical cluster analysis of the data revealed a possible association with a small group of four cytokines, comprising IL-1β, IL-13, IL-6/CRP and TGF-β1. CONCLUSIONS : This study confirms a strong association of established mCRC with cytokine-driven systemic inflammation. Four of these cytokines, IL-1β/IL-13 IL-6/CRP, and TGF-β1, appear prominent and are possibly indicative of novel targetable therapeutic options.
  • Item
    Exploring the challenges and legal implications of secondary use of health data in South Africa
    Edgcumbe, Aliki; Strydom, Adéle; Thaldar, Donrich Willem; Pepper, Michael Sean (Wiley, 2026)
    The sharing of health data advances knowledge, fosters innovation, and promotes evidence-based decision-making. This practice involves using existing data for collaborative research or for purposes other than those for which it was originally collected. In South Africa, the secondary use of health data has significant potential to inform policy decisions, advance scientific research, and address societal challenges. However, the use of health data for secondary purposes in the public health sector is faced with several challenges and legal complexities. This article examines these challenges and legal dimensions, with particular attention to the regulatory framework governing health data in South Africa, including issues of consent, privacy, data ownership, and intellectual property rights. Understanding these legal considerations enables stakeholders to navigate the complexities of secondary data use in an ethically sound and legally compliant manner.
  • Item
    Beyond the M-spike - immunoparesis and multiple myeloma. A narrative review
    Mayne, Elizabeth Sarah; ; Wiggill, Tracey Monica; Worsley, Catherine Mary (Elsevier, 2027-02)
    Secondary immunodeficiency or immunoparesis is an acquired impairment of the immune system which is a recognised feature of multiple myeloma (MM). Although classically described as a reduced production of polyclonal immunoglobulins, MM induces global immune dysfunction with defects in innate immune and T cell effector function. Immunoparesis can be detected in premalignant states, including monoclonal gammopathy of uncertain significance. Patients with immunoparesis have a poorer prognosis and present with severe, recurrent infection, which is associated with increased morbidity and mortality especially in the first 3 months following diagnosis, with relapse or progression and with the use of novel therapeutics. Bacterial infections, and specifically pneumonia, are the commonest presentation although there are increased risks of both viral reactivation and invasive fungal infection. Management of immunoparesis in MM includes the use of antimicrobial prophylaxis, and immunoglobulin replacement therapy particularly during high-risk periods. Although vaccination against encapsulated organisms, reactivation viruses, and circulating seasonal viruses is recommended, the response in MM may be suboptimal. HIGHLIGHTS • Multiple myeloma causes global immune dysfunction. • Immunoparesis increases mortality especially immediately following diagnosis. • Patients present with increased and recurrent infection and atypical infections. • Benefit of therapeutic approaches like immunoglobulin replacement is unclear. • Immunoparesis may be a consideration when selecting novel therapies for myeloma.
  • Item
    A national survey of therapeutic facilities for managing hypoxic ischaemic encephalopathy in tertiary neonatal wards in South African public hospitals
    Dhlomo, N.N.; Pepper, Michael Sean; Van Rensburg, Jeanne; Horn, A.R. (Health and Medical Publishing, 2025-12)
    BACKGROUND : A 2011 South African (SA) survey noted substantial variability in provision of therapeutic hypothermia (TH) for moderate-severe neonatal encephalopathy due to suspected hypoxic-ischaemic encephalopathy (NESHIE). OBJECTIVES : To describe facilities, including TH, for babies with NESHIE in SA tertiary/specialised public hospitals. METHODS : A survey was emailed to representatives of all public tertiary/specialised hospitals with tertiary neonatal beds in SA. The survey contained questions regarding bed numbers, equipment, staffing, follow-up and barriers to the implementation of TH. RESULTS : Responses were received from all 25 hospitals across the nine provinces. Most hospitals (n/N=22/25; 88%) provided TH (median (range) per province: 2 (1 - 8)). The hospitals providing TH had more total neonatal beds (p=0.011) and more admissions with moderate-severe NESHIE (p=0.008) compared with those not providing TH. Most cooling centres (n/N=20/22; 91%) provided TH in their NICUs; six of these also cooled at lower levels of care. There was access to amplitude integrated electroencephalography (aEEG) and automated cooling in 91% of cooling centres. Manual cooling was used by 50% if automated TH was not available, 82% of which were validated methods. Late arrival was the most frequent barrier to provision of TH (80%). CONCLUSION : All provinces and most tertiary/specialised hospitals with tertiary neonatal beds in SA provided TH in 2023. The use of acceptable monitoring and cooling methods was widespread but insufficient, and some cooling methods in use were not validated. National registers and standardised protocols for patient selection and management are needed.
  • Item
    Modulation of HMGB1, PRF1, TRAIL, and M-CSF after TARGIT-IORT in breast-conserving surgery : defining a unique acute immune landscape
    Ramdas, Yastira; Worsley, Catherine Mary; Meyer, Pieter Willem Adriaan; Benn, Carol-Ann (Springer, 2026)
    BACKGROUND : Targeted intraoperative radiotherapy (TARGIT-IORT) delivers a single high-dose boost to the tumor bed during breast-conserving surgery (BCS) and is now recommended only within clinical trials or registries. Its acute systemic immunogenic effects relative to BCS-only are not well characterized. METHODS : Women with histologically confirmed breast carcinoma were allocated in an alternating 1:1 sequence to BCS + TARGIT-IORT or BCS-only groups. Peripheral blood was sampled pre-operatively and 24 h post-surgery. ICD and cytokine/DAMP mediators, including HMGB1, PRF1, TRAIL, FASL-NFSF6, CASP-8, GZMB, CRT, TLR4, RAGE, GDF15, and M-CSF, were quantified using ELISA. Perioperative changes were analyzed using the Wilcoxon signed-rank test; between-group Δ differences were assessed using the Mann-Whitney U test. RESULTS : Forty-two patients were enrolled (26 BCS + TARGIT-IORT; 16 BCS-only). TARGIT-IORT induced a distinct early immune shift across ICD markers. HMGB1 showed the most pronounced change (3410.5 → 359.8 pg/ml; p < 0.001), significantly greater than that after BCS-only (1040.7 → 263.6 pg/ml; Δp < 0.001). TRAIL (246.1 → 155.5 pg/ml; p = 0.001) and FASL-NFSF6 (1087.1 → 839.3 pg/ml; p = 0.003) also declined significantly after TARGIT-IORT, whereas changes following BCS alone were modest. TARGIT-IORT increased M-CSF (266.7 → 386.7 pg/ml; p = 0.037) and reduced TLR4 (1456.3 → 1331.3 ng/ml; p = 0.007), with no significant perioperative changes in RAGE, GDF15, CRT, GZMB, or CASP-8. DISCUSSION : Within 24 h, TARGIT-IORT generates a coordinated ICD-related and cytokine/DAMP signature, marked HMGB1 depletion, death ligand modulation, TLR4 engagement, and M-CSF upregulation, consistent with rapid immune priming. These findings are exploratory and should be interpreted within a translational framework. Larger, randomized multicentre studies with extended longitudinal and tissue-level immune profiling are needed to confirm these signals.
  • Item
    Building a type 1 diabetes registry in South Africa : insights from a national multi-stakeholder workshop
    Ngassa Piotie, Patrick; Modipane, Penelope; Carrihill, Michelle; Kruger, Michelle; Lazaridis, Marina; Kruger, Adriaan; Shankland, Luke; Klinck, Elsabe; Castelyn, Camille De Villebois; Mwangi, Joseph Kibachio; Pienaar, Melanie; Muchengeti, Mazvita (AOSIS, 2026-07-31)
    No abstract available.
  • Item
    The role of angiogenesis in breast cancer and obesity : unravelling the connection
    Sikuza, Yolo O.K.; Basson, Charlise; Oberholzer, Nanette; Ambele, Melvin Anyasi (Wiley, 2026-06)
    Breast cancer remains one of the leading causes of cancer-related mortality amongst women worldwide, with rising incidence rates paralleling the global obesity epidemic. Obesity has been increasingly recognised as a risk factor for breast cancer, yet the molecular mechanisms underlying the association remain poorly understood. This review explores the role of angiogenesis as the central mechanism linking obesity to breast cancer progression. Angiogenesis is essential for both adipose tissue expansion and tumour growth. It is dysregulated in obesity and breast cancer, resulting in the formation of abnormal vasculature that perpetuates hypoxia and malignancy. Obesity contributes to this process through hypertrophic adipose tissue, altered adipokine profiles and elevated expression of proangiogenic factors, such as VEGF. These changes create a tumour microenvironment conducive to cancer progression, treatment resistance and poor clinical outcomes. Emerging evidence also implicates endothelial cells, pericytes and lipid metabolism in this interaction, suggesting novel therapeutic targets.
  • Item
    Mechanistic links between obesity and breast cancer progression : cellular crosstalk, metabolic reprogramming and microenvironmental drivers
    Basson, Charlise; Pepper, Michael Sean; Joubert, Anna Margaretha; Ambele, Melvin Anyasi (Wiley, 2026-07)
    Obesity is increasingly recognised as an important factor contributing to cancer progression, particularly in breast cancer. However, the cellular and molecular mechanisms underlying obesity-driven breast cancer remain unclear. Several theories have been proposed to explain the complex interactions between adipose tissue and cancer, incorporating both local and distant crosstalk. This review describes existing theories on the cellular and molecular mechanisms linking obesity and breast cancer progression with a focus on inflammation, oxidative stress, metabolic reprogramming, the tumour microenvironment and crosstalk between adipose tissue and tumours. The nature of these interactions appears to be influenced by the specific characteristics of adipose tissue, including its type and anatomical location, which play distinct roles in modulating breast cancer risk and outcomes. Understanding the cellular and molecular mechanisms that underlie obesity-driven breast cancer progression may pave the way for the development of targeted therapies. SUMMARY Obesity is a major modifiable risk factor for breast cancer incidence, progression and metastasis. Despite the reported association between obesity and poor breast cancer outcomes, the exact underlying biological mechanisms remain incompletely defined. Theories on the cellular and molecular mechanisms underlying the cancer–obesity relationship include direct adipose–tumour interactions, inflammation, oxidative stress and metabolic reprogramming. Understanding how obesity-associated factors influence breast cancer is essential for improving current therapies and identifying new therapeutic targets in patients with obesity.
  • Item
    The Potassium-uptake systems, Trk and Kdp, coordinately contribute to growth regulation and survival of M. tuberculosis in ion-depleted and acidic environments
    Osman, Ayman Gassim Elamin; Matjokotja, Maborwa T.; Allam, Mushal; Ismail, Arshad; Anderson, Ronald; Cholo, Moloko C. (MDPI, 2026-05)
    The Mycobacterium tuberculosis bacterium encodes two active potassium (K+)-uptake transport systems, the Trk and the Kdp. The Trk is the low-affinity K+ transporter, consisting of two TrkA proteins, while the Kdp consists of the high-affinity K+ transporter KdpFABC and the two-component system KdpDE. Both transporters are utilised by the bacteria for growth and survival. During growth, the bacteria utilise the constitutively expressed Trk and suppress the Kdp, but upregulate both transporters during survival. In the current study, we investigated the interactive effects of these systems on bacterial growth and survival. This was achieved by first constructing a M. tuberculosis mutant strain in which both the Trk and Kdp systems were inactivated by homologous recombination. The mutant was evaluated for its growth kinetics in planktonic cultures, as well as survival in biofilm and macrophage cultures. The constructed M. tuberculosis mutant showed faster growth rates in planktonic cultures, but was attenuated for both biofilm formation and intracellular survival in isolated human monocyte-derived macrophages. These results illustrate that both K+-uptake systems are essential to sustain slow rates of bacterial growth, as well as for bacterial persistence in hostile environments via optimisation of biofilm formation, and intracellular survival in macrophages. (Words: 194).
  • Item
    Flavonol-mediated modulation of angiogenesis-related microRNAs in breast cancer : a narrative synthesis of current evidence and knowledge gaps
    Ramali, Dakalo Portia; Maphoso, Tania Mmapule; Mulaudzi, Thanyani Victor; Ambele, Melvin Anyasi; Maharaj, Vinesh J.; Mabeta, Peaceful Lucy; Damane, Botle Precious (Taylor and Francis, 2026-05-08)
    Angiogenesis is essential for breast cancer progression and metastasis; however, the clinical impact of vascular endothelial growth factor (VEGF)-targeted therapies remains limited due to adaptive resistance and activation of compensatory angiogenic pathways. Angiogenesis-regulating microRNAs (angiomiRs) act as upstream modulators of both VEGF-dependent and VEGF-independent signaling networks contributing to vascular plasticity, immune evasion, and therapeutic escape. Dietary flavonols such as kaempferol, myricetin, and quercetin have demonstrated anti-angiogenic activity in preclinical models, yet their mechanistic interaction with angiomiR-mediated regulation in breast cancer remains poorly characterized. This narrative review critically evaluates evidence identified through structured searches of Google Scholar, PubMed, Scopus, and Web of Science (2010–2026). We synthesize mechanistic and translational findings linking flavonols to microRNA-associated regulation of hypoxia signaling, endothelial activation, extracellular vesicle communication, and vascular normalization. Available evidence indicates that flavonols may influence angiogenic pathways both directly, by inhibiting key signaling cascades, and indirectly, through modulation of non-coding RNA networks. Despite these insights, experimental validation of specific flavonol-angiomiR interactions in breast cancer remains limited. AngiomiR modulation by flavonols, therefore, represents a mechanistically grounded but predominantly preclinical concept that warrants further translational investigation to clarify its therapeutic relevance and potential applications within precision oncology in breast cancer. PLAIN LANGUAGE SUMMARY : Blood vessels are essential for supplying breast cancer tumors with nutrients and oxygen. Tumors often rely on a molecule called vascular endothelial growth factor (VEGF) to form new blood vessels. For this reason, treatments that block VEGF have been developed to slow tumor growth. However, these treatments can lose effectiveness over time because cancer cells can find alternative ways to keep their blood supply. Blood vessel formation is controlled by signals within cells. MicroRNAs (miRNAs) are very small molecules that help turn genes on or off, influencing how blood vessels develop and how tumors respond to treatment. Flavonols are naturally occurring compounds found in certain fruits and vegetables. Some studies suggest that flavonols can affect blood vessel growth, possibly by influencing miRNAs involved in this process. Although early findings are promising, most evidence comes from laboratory and preclinical studies. Further research is needed to determine whether targeting these pathways could lead to safe and effective treatment strategies for patients with breast cancer.
  • Item
    The effects of in utero HIV and antiretroviral therapy exposure on infant T-cell and monocyte activation, function, and regulation of immune-modulatory pathways
    Prinsloo, Andrea; Steel, Helen Carolyn; Feucht, Ute Dagmar; Rossouw, Theresa M. (Wiley, 2026-03)
    Human immunodeficiency virus (HIV) infection is characterized by chronic, systemic immune activation. It is unclear how this affects the immune system of infants born to mothers living with HIV (MLWH). The current study assessed whether maternal HIV status and in utero antiretroviral therapy (ART) exposure impact infant T-cell and monocyte activation and regulation, as well as monocyte responsiveness to stimulation at birth and early infancy. T-cell and monocyte activation and expression of immune checkpoint molecules were characterized by means of flow cytometry. Pro- and anti-inflammatory cytokine/chemokine profiles were assessed using a suspension bead array assay. Seventy-one pregnant MLWH and 77 mothers not living with HIV (MNLWH) were recruited at 22 weeks’ gestation, and mother-infant pairs were followed until 6 months postpartum. MLWH had higher percentages of CD4+ and CD8+ T-cells expressing programmed cell death protein-1 (PD-1) and a higher percentage of regulatory T-cells (Tregs). HIV-exposed-but-uninfected (HEU) infants displayed disrupted CD4+ T-cell maturation with an increased number of CD8+ T-cells expressing PD-1 at the time of birth and increased T-cell exhaustion at 10 weeks of age. Higher levels of monocyte activation were observed in MLWH with increased numbers of classical (CL) monocytes expressing CCR2 and CD80. An increased percentage of CL monocytes expressing CCR2 and CD80 was noted in HEU infants at the time of birth, which persisted at 10 weeks of age. Significantly higher levels of C-reactive protein (CRP) and non-significantly higher levels of interleukin (IL)-6 and tumor necrosis factor-alpha were observed in MLWH, indicative of hyperactivated innate inflammation. HEU infants had persistently increased levels of IL-8 and transforming growth factor (TGF)-β1, and lower levels of IL-10, IFN-γ, and CRP. The latter might be secondary to cotrimoxazole use in the HEU infants while the altered cytokine levels might be indicative of altered immune programing. In summary, this cohort study showed that maternal HIV status has a transient effect on basal infant T-cell and monocyte activation, regulation, and monocyte responsiveness, which dissipates at 6 months of age, while altered cytokine levels persisted.
  • Item
    HIV resistance to dolutegravir varies with co-administered agents
    Beck, Ingrid A.; Boyce, Ceejay L.; Bishop, Marley D.; Oldroyd, Alyssa R.; Du Toit, Louise de Villiers; Saimen, Amashnee; Ramarope, Kholofelo Mn; Hitchcock, Sonia; Du Plessis, Nicolette Marie; Mbogo, Loice; Chohan, Bhavna H.; Maheria, Pooja; Oyaro, Patrick; Knowles, Kevin; Zhang, Zhongli; Brummel, Sean S.; Drain, Paul K.; Smith, Robert A.; Gottlieb, Geoffrey S.; Abuogi, Lisa; Patel, Rena C.; Farquhar, Carey; Wiznia, Andrew; Ruel, Theodore D.; Rossouw, Theresa M.; Hawes, Stephen E.; Frenkel, Lisa M. (Oxford University Press, 2026-04-15)
    We hypothesized that HIV-dolutegravir resistance is more frequent when coadministered with nucleos(t)ides with shorter intracellular half-lives. Multivariable analysis of 183 viremic (≥200 c/mL) participants from 4 cohorts (N = 660 participants) found dolutegravir resistance in 21 (11.5%). Dolutegravir resistance was greater with dolutegravir + lamivudine + zidovudine/(1 on stavudine) (odds ratio [OR] = 19.4, 95% confidence interval [CI]: 5.1–74.3) or dolutegravir + lamivudine +abacavir (OR = 5.4, 95% CI: 1.1–25.8), compared with dolutegravir + lamivudine + tenofovir.